<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-1548128325933368660</id><updated>2010-07-04T14:21:36.646-03:00</updated><title type='text'>eSaúde - PEP - RES - Pesquisa Clínica</title><subtitle type='html'>Segundo a HIMSS - Healthcare Information and Management Systems Society -, eHealth é qualquer aplicação de Internet, utilizada em conjunto com outras tecnologias de informação, focada na melhoraria do acesso, da eficiência, da efetividade e da qualidade dos processos clínicos e assistenciais necessários a toda a Cadeia de Atendimento à Saúde.</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><link rel='next' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default?start-index=26&amp;max-results=25'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>75</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-6312187668480680515</id><published>2010-07-02T09:59:00.007-03:00</published><updated>2010-07-04T14:21:36.659-03:00</updated><title type='text'>I I I - WIKI MEETING EM PESQUISA CLÍNICA</title><content type='html'>&lt;span class="Apple-style-span" style="font-family: Arial; font-size: 18px; line-height: 15px;"&gt;&lt;b&gt;&amp;nbsp;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp;&lt;a href="http://translate.google.com/translate?js=y&amp;amp;prev=_t&amp;amp;hl=en&amp;amp;ie=UTF-8&amp;amp;layout=1&amp;amp;eotf=1&amp;amp;u=http://esaude.eassertiva.com.br/&amp;amp;sl=auto&amp;amp;tl=es"&gt;Spanish version&lt;/a&gt;&amp;nbsp;. &lt;/b&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold';"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-size: 18px; font-weight: normal; line-height: 15px;"&gt;&lt;b&gt;&amp;nbsp;&lt;a href="http://translate.google.com/translate?js=y&amp;amp;prev=_t&amp;amp;hl=en&amp;amp;ie=UTF-8&amp;amp;layout=1&amp;amp;eotf=1&amp;amp;u=http://esaude.eassertiva.com.br/&amp;amp;sl=auto&amp;amp;tl=en"&gt;English version&lt;/a&gt;&amp;nbsp;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold';"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold';"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: normal; line-height: 15px;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold';"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;Pesquisa Clínica no Brasil:&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;&amp;nbsp;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold';"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;III &amp;nbsp;Wiki Meeting com a participação da ANVISA.&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold';"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold';"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;DATA: 25 de Setembro de 2010 - São Paulo.&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;div class="blogPost" style="font-family: 'Trebuchet MS', Trebuchet, Verdana, sans-serif; font-size: 16px; margin-bottom: 30px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span class="Apple-style-span" style="color: red; font-family: 'Verdana Bold'; font-weight: bold;"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="background-color: white;"&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;Informações e Inscrições:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red; font-family: 'Verdana Bold'; font-weight: bold;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red; font-family: 'Verdana Bold'; font-weight: bold;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red; font-family: 'Verdana Bold'; font-weight: bold;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red; font-family: 'Verdana Bold'; font-weight: bold;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red; font-family: 'Verdana Bold'; font-weight: bold;"&gt;&lt;div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="background-color: white;"&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span" style="color: blue;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;(VAGAS LIMITADAS)&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&amp;nbsp;através do&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="background-color: white;"&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 5px; -webkit-border-vertical-spacing: 5px; font-family: Helvetica, Arial, Helvetica, sans-serif;"&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;e-mail:&lt;span class="Apple-style-span" style="color: blue;"&gt;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;a href="mailto:sac@eassertiva.com.br"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;span class="Apple-style-span" style="color: blue;"&gt;sac@eassertiva.com.br&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;&lt;div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;b&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span" style="background-color: white;"&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 5px; -webkit-border-vertical-spacing: 5px; font-family: Helvetica, Arial, Helvetica, sans-serif; font-size: 11px;"&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red; font-family: 'Verdana Bold';"&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="color: red; font-family: 'Verdana Bold';"&gt;&lt;b&gt;Programação – PRELIMINAR&amp;nbsp;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold'; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red; font-family: 'Verdana Bold';"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold'; font-weight: bold;"&gt;8:00h - 8:30h - Recepcão dos participantes e Café.&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold'; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold'; font-weight: bold;"&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold'; font-weight: bold;"&gt;8:30h - 08:45h - Abertura e boas vindas dos facilitadores .&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold'; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold'; font-weight: bold;"&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold'; font-weight: bold;"&gt;8:45h - 9:00h - Apresentação dos participantes.&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;span style="color: black; font-family: 'Verdana Bold';"&gt;9:00h – 10:00h - Contribuição da ANVISA –&amp;nbsp;&lt;/span&gt;&lt;span style="color: black; font-family: 'Verdana Bold';"&gt;Dr. Marcelo Sidi, da Gerência Geral de Cosméticos.&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold'; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;span style="color: black; font-family: 'Verdana Bold';"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold'; font-weight: bold;"&gt;10:00h – 11:00h - Contribuição da ANVISA - Dr. Alessandro Ferreira do Nascimento - Coordenação de Pesquisas e Ensaios Clínicos – COPEM/GESEF/Gerência Geral de Medicamentos – GGMED.&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold'; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold'; font-weight: bold;"&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold'; font-weight: bold;"&gt;11:00h – 11:15h – Coffe Break.&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;span style="color: black; font-family: 'Verdana Bold';"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold'; font-weight: bold;"&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;span style="color: black; font-family: 'Verdana Bold';"&gt;11:15h -12:15h – Contribuição dos&amp;nbsp;&lt;/span&gt;&lt;span style="color: black; font-family: 'Verdana Bold';"&gt;&amp;nbsp;Centros de Pesquisa em Cosméticos.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="blogPost" style="font-family: 'Trebuchet MS', Trebuchet, Verdana, sans-serif; font-size: 16px; margin-bottom: 30px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;div class="MsoNormal"&gt;&lt;span class="Apple-style-span" style="font-family: 'Verdana Bold';"&gt;12:15h – 13:00h - Contribuição dos Centros de Pesquisa.&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: black; font-family: 'Verdana Bold';"&gt;13:00h – 14:00h – ALMOÇO.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: black; font-family: 'Verdana Bold';"&gt;14:00h – 14:45h - Contribuição dos representantes de CEPs.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: black; font-family: 'Verdana Bold';"&gt;14:45h - 15:30h - Contribuição das Indústrias Farmacêuticas/Cosméticos.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: black; font-family: 'Verdana Bold';"&gt;15:30h – 15:45h – Coffe Break.&amp;nbsp;&lt;/span&gt;&lt;span style="color: black; font-family: 'Verdana Bold';"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: black; font-family: 'Verdana Bold';"&gt;15:45h – 16:30h – Contribuição das CROs .&amp;nbsp;&lt;/span&gt;&lt;span style="color: black; font-family: 'Verdana Bold';"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;span style="color: black; font-family: 'Verdana Bold';"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: black; font-family: 'Verdana Bold';"&gt;16:30h – 17:30h – Definição, encaminhamento dos assuntos debatidos e encerramento.&lt;/span&gt;&lt;span style="color: black; font-family: 'Verdana Bold';"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial;"&gt;&lt;b&gt;Patrocinadores:&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial;"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial;"&gt;&lt;b&gt;Ouro:&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://3.bp.blogspot.com/_vqAAVB4XMoI/TCxdDkj2JnI/AAAAAAAAAA8/TK1XK1RaNa8/s1600/logo-Interfarma20anos.jpg" imageanchor="1" style="clear: left; color: #de7008; float: left; margin-bottom: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="87" src="http://3.bp.blogspot.com/_vqAAVB4XMoI/TCxdDkj2JnI/AAAAAAAAAA8/TK1XK1RaNa8/s320/logo-Interfarma20anos.jpg" width="320" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;span class="Apple-style-span" style="font-family: Arial;"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;Prata:&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://3.bp.blogspot.com/_vqAAVB4XMoI/TCxjLj96E9I/AAAAAAAAABE/l_WS0wFGbD4/s1600/logo_scentryphar_rgb_cor.jpg" imageanchor="1" style="clear: left; color: #de7008; float: left; margin-bottom: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="91" src="http://3.bp.blogspot.com/_vqAAVB4XMoI/TCxjLj96E9I/AAAAAAAAABE/l_WS0wFGbD4/s200/logo_scentryphar_rgb_cor.jpg" width="200" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;Bronze:&amp;nbsp;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://4.bp.blogspot.com/_vqAAVB4XMoI/TCxm-wu6rrI/AAAAAAAAABM/SPc_Hn6p2iU/s1600/logo_worldcourier.jpg" imageanchor="1" style="clear: left; color: #de7008; float: left; margin-bottom: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="45" src="http://4.bp.blogspot.com/_vqAAVB4XMoI/TCxm-wu6rrI/AAAAAAAAABM/SPc_Hn6p2iU/s200/logo_worldcourier.jpg" width="200" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-weight: bold;"&gt;Apresentação da e-ASSERTIVA e do WIKI MEETING EM PESQUISA CLÍNICA.&lt;/span&gt;&lt;br /&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span class="Apple-style-span" style="font-size: large;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-size: large;"&gt;A e-ASSERTIVA é uma empresa de colaboração científica, distribuição, integração de conteúdos e tecnologias na área médica, farmacêutica e cosmética. Ao longo desses últimos anos a e-ASSERTIVA tem se destacado por sua inovação na produção e transmissão de conteúdos on-line sobre Pesquisa Clínica, pois acreditamos que, para uma Pesquisa Clínica ser bem sucedida, todos os envolvidos deve estar em constante comunicação, independentemente das distâncias.&lt;/span&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;Dentre os serviços de grande impacto oferecidos pela e-ASSERTIVA podemos citar o&lt;a href="http://www.eassertiva.com.br/redewiki.asp" style="color: #de7008;"&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&amp;nbsp;WIKI MEETING&lt;/span&gt;&lt;/a&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;,&lt;/span&gt;&amp;nbsp;encontro anual realizado entre autoridades de órgãos regulatórios, centros conceituados em pesquisa clínica na área médica, farmacêutica e cosmética, parceiros da e- ASSERTIVA como PRÓ-GENÉRICOS, INTERFARMA, Associação Brasileira dos Centros de Bioequivalência (ACBIO) e outros de igual importância.&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 15.4px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;Justificativa do Evento&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;A pesquisa é um processo de construção do conhecimento que tem como metas principais gerar novo conhecimento e/ou refutar algum conhecimento pré-existente. É&amp;nbsp;basicamente um processo de aprendizagem tanto do profissional que a realiza quanto da sociedade na qual esta se desenvolve. A sociedade e a comunidade beneficiam-se com a aplicação do novo conhecimento gerado nos indivíduos que a compõe.&lt;/span&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;Os avanços tecnológicos e esforços científicos para divulgação do conhecimento que vem ocorrendo nas últimas décadas colocam os profissionais ligados a pesquisa frente ao desafio de se manter continuamente atualizados. Sendo assim e levando em consideração que a troca de informações fortalece as partes envolvidas e enriquecem os trabalhos oferecidos e tendo em vista a importância da pesquisa em seres humanos para o desenvolvimento da ciência na produção de novas tecnologias na área médica, farmacêutica e cosmética, a ASSERTIVA – Gestão da Informação e Colaboração Científica - promove o III WIKI MEETING EM PESQUISA CLÍNICA, na seqüência dos bem sucedidos I e II WIKI MEETING, onde muitos obstáculos ligados a pesquisa clínica foram identificados e transpostos, tais como: a falta de conhecimento e ética, legislação inadequada, visão ineficiente da pesquisa, entre outros.&lt;/span&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 15.4px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 15.4px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;Estrutura do Wiki Meeting em Pesquisa Clínica:&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-size: large;"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;1. Evento:&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;O evento WIKI MEETING EM PESQUISA CLÍNICA é apoiado pelo Ministério da Saúde que regulamenta e supervisiona as práticas de pesquisa clínica no Brasil, através do envio de profissionais específicos da ANVISA (Agência Nacional de Vigilância Sanitária) e da CONEP (Comissão Nacional de Ética em Pesquisa), também ligada ao Ministério da Saúde, responsável pela avaliação dos projetos de pesquisa no que se refere aos aspectos éticos das pesquisas propostas pelos laboratórios patrocinadores.&lt;/span&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;Os palestrantes do WIKI MEETING representam as comunidades científica, industrial e política que estão engajados numa estratégia de implementação da troca de informações a fim de fortalecer as partes envolvidas e enriquecer as pesquisas a serem realizadas.&lt;/span&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;2. A política em Mesa Redonda:&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span class="Apple-style-span" style="font-size: large;"&gt;Com a participação dos representantes da ANVISA e CONEP entre outros profissionais ligados a pesquisa clínica nas áreas médica, farmacêutica e cosmética será possível discutir sobre legislação, identificar e erradicar obstáculos, além de fornecer soluções que funcionam para aplicação e desenvolvimento da Pesquisa Clínica no Brasil.&lt;/span&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 15.4px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 15.4px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;Público Alvo:&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span class="Apple-style-span" style="font-size: large;"&gt;Como estamos interessados numa rede de aperfeiçoamento e desenvolvimento, os grupos focados são: indústrias nas áreas médica, farmacêutica e cosmética, membros governamentais, associações ligadas à pesquisa clínica, instituições financeiras, centros de pesquisas e os profissionais em geral envolvidos com pesquisa clínica.&lt;/span&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;PRESENÇAS CONFIRMADAS NO III WIKI MEETING EM PESQUISA CLÍNICA&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span class="Apple-style-span" style="color: #0c0208; font-size: 18px;"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: #0c0208; font-size: 18px;"&gt;&lt;b&gt;- Dr. Alessandro Ferreira do Nascimento - Coordenação de Pesquisas e Ensaios Clínicos - COPEM/GESEF/Gerência Geral de Medicamentos - GGMED.&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: orange;"&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="color: black; font-family: Helvetica; font-size: medium; font-weight: normal;"&gt;&lt;span class="Apple-style-span" style="color: #0c0208;"&gt;&lt;span class="Apple-style-span" style="font-family: Arial; font-size: large;"&gt;&lt;span class="Apple-style-span" style="font-size: 18px;"&gt;&lt;b&gt;&lt;br /&gt;- Dr. Marcelo Sidi, da Gerência Geral de Cosméticos - ANVISA&lt;/b&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: orange;"&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: orange;"&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="color: black; font-family: 'Trebuchet MS', Trebuchet, Verdana, sans-serif; font-size: 16px; font-weight: normal;"&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;b&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span class="Apple-style-span" style="font-size: large;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font: normal normal normal 11.3px/normal Arial; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;/div&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: red;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-6312187668480680515?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/6312187668480680515/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=6312187668480680515' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/6312187668480680515'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/6312187668480680515'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2010/07/i-i-i-wiki-meeting-em-pesquisa-clinica_02.html' title='I I I - WIKI MEETING EM PESQUISA CLÍNICA'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/_vqAAVB4XMoI/TCxdDkj2JnI/AAAAAAAAAA8/TK1XK1RaNa8/s72-c/logo-Interfarma20anos.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-1366556063413320345</id><published>2010-05-13T19:39:00.002-03:00</published><updated>2010-06-04T14:21:11.969-03:00</updated><title type='text'>CLINICAL TRIALS IN LATIN AMERICA - SEPTEMBER 9-10,2010 * LIMA,PERU.</title><content type='html'>&lt;span class="Apple-style-span" style="font-family: 'Lucida Grande'; font-size: small;"&gt;&lt;span class="Apple-style-span" style="font-size: 11px;"&gt;&lt;span class="Apple-style-span" style="font-family: Times; font-size: medium;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: 'Lucida Grande'; font-size: small;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: 'Lucida Grande'; font-size: small;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: 'Lucida Grande';"&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; border-collapse: collapse;"&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px; border-collapse: separate; font-family: Times;"&gt;&lt;table align="center" cellpadding="0" cellspacing="0"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td valign="top"&gt;&lt;div align="center"&gt;&lt;center&gt;&lt;table bgcolor="#ffffff" bordercolor="#111111" cellpadding="0" style="border-bottom-color: rgb(0, 0, 0); border-bottom-style: solid; border-bottom-width: 5px; border-collapse: collapse; border-left-color: rgb(0, 0, 0); border-left-style: solid; border-left-width: 5px; border-right-color: rgb(0, 0, 0); border-right-style: solid; border-right-width: 5px; border-top-color: rgb(0, 0, 0); border-top-style: solid; border-top-width: 5px; width: 596px;"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center" valign="top"&gt;&lt;img border="0" height="204" src="http://www.cbinet.com/events/logos/Miscellaneous/PC10029_Emailheader2.gif" width="600" /&gt;&lt;table border="1" cellspacing="0" id="table20"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="middle" bgcolor="#000000" bordercolor="#028641" width="161"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px;"&gt;&lt;span style="color: white; font-family: Calibri;"&gt;&lt;span style="text-decoration: none;"&gt;&lt;span style="color: white; font-size: 11pt;"&gt;&lt;span style="font-weight: 700; text-decoration: none;"&gt;&lt;a href="http://www.cbinet.com/requestBrochure.cfm?confCode=PC10029&amp;amp;field=brochure"&gt;&lt;span style="color: white;"&gt;REQUEST BROCHURE&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td align="middle" bgcolor="#000000" bordercolor="#028641" width="120"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px;"&gt;&lt;span style="color: white; font-family: Calibri;"&gt;&lt;span style="text-decoration: none;"&gt;&lt;span style="color: white; font-size: 11pt;"&gt;&lt;span style="font-weight: 700; text-decoration: none;"&gt;&lt;a href="http://www.cbinet.com/show_conference.cfm?confCode=PC10029&amp;amp;field=conferencePricing"&gt;&lt;span style="color: white;"&gt;REGISTER&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td align="middle" bgcolor="#000000" bordercolor="#028641" width="155"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px;"&gt;&lt;span style="color: white; font-family: Calibri;"&gt;&lt;span style="text-decoration: none;"&gt;&lt;span style="color: white; font-size: 11pt;"&gt;&lt;span style="font-weight: 700; text-decoration: none;"&gt;&lt;a href="http://www.cbinet.com/show_conference.cfm?confCode=PC10029"&gt;&lt;span style="color: white;"&gt;VIEW WEBSITE&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td align="middle" bgcolor="#000000" bordercolor="#028641" width="146"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px;"&gt;&lt;b&gt;&lt;a href="http://www.cbinet.com/referacolleague.cfm?ConfCode=pc10029"&gt;&lt;span style="color: white; font-family: Calibri; font-size: 11pt;"&gt;REFER COLLEAGUES&lt;/span&gt;&lt;/a&gt;&lt;/b&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top"&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 600px;"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td bgcolor="#ffffff" style="padding-bottom: 0px; padding-left: 10px; padding-right: 10px; padding-top: 10px;" valign="top" width="380"&gt;&lt;table bordercolor="#111111" cellpadding="3" style="border-bottom-color: rgb(192, 192, 192); border-bottom-style: solid; border-bottom-width: 2px; border-collapse: collapse; border-left-color: rgb(192, 192, 192); border-left-style: solid; border-left-width: 2px; border-right-color: rgb(192, 192, 192); border-right-style: solid; border-right-width: 2px; border-top-color: rgb(192, 192, 192); border-top-style: solid; border-top-width: 2px; color: black; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 11px; font-style: normal; font-variant: normal; font-weight: normal; width: 579px;"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center" valign="top"&gt;&lt;table border="0" cellpadding="0" cellspacing="0" id="table1"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left" valign="top" width="278"&gt;&lt;table border="2" bordercolor="#028641" cellpadding="0" cellspacing="0" id="table2"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td bgcolor="#F0F0F0"&gt;&lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;b&gt;&lt;span style="color: #028641; font-family: Arial;"&gt;&lt;span style="font-size: 11pt; font-style: italic;"&gt;Conference Co-Chairs:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="color: black; font-family: Arial; font-size: 9pt;"&gt;Gustavo Kesselring, M.D., Director, Clinical Operations, Clinical Research Center,&lt;b&gt;Oswaldo Cruz Hospital, São Paulo Brazil&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="color: black; font-family: Arial; font-size: 9pt;"&gt;Jorge L. Vinces, M.D., Global Medical Affairs Lead, Mexico-Perú,&amp;nbsp;&lt;b&gt;Merck &amp;amp; Co.&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;b&gt;&lt;span style="color: #028641; font-family: Arial; font-style: italic;"&gt;&lt;span style="font-size: 11pt;"&gt;&lt;br /&gt;Elite Speaking Faculty Includes:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: 14px; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: 9pt;"&gt;Carlos Seminario, M.D., Regional Clinical Quality Director, Latin America,&amp;nbsp;&lt;/span&gt;&lt;b&gt;&lt;span style="font-size: 9pt;"&gt;AstraZeneca&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: 14px; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: 9pt;"&gt;Luis Rios-Nogales, M.D., Ph.D., MBA, Regional Medical Director and Head Clinical Research, Latin America Region,&lt;/span&gt;&lt;b&gt;&lt;span style="font-size: 9pt;"&gt;AstraZeneca&lt;/span&gt;&lt;/b&gt;&lt;span style="font-size: 9pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: 14px; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: 9pt;"&gt;Juan Luis Yrivarren, M.D., Research Director,&lt;b&gt;Centro Investigación Ricardo Palma&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: 14px; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: 9pt;"&gt;Nicolas Sandoval, SCRA/CTL/LRA, Clinical Team Leader and Local Regulatory Adviser, Clinical Operations, Lima, Peru,&amp;nbsp;&lt;b&gt;INC Research&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: 14px; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="font-family: Arial;"&gt;&lt;span style="font-size: x-small;"&gt;Carlos&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Arial;"&gt;&lt;span style="font-size: x-small;"&gt;Vallejos Sologuren,&amp;nbsp;&lt;span lang="ES"&gt;Institutional Chief&lt;/span&gt;&lt;/span&gt;&lt;span lang="ES"&gt;&lt;span style="font-size: x-small;"&gt;,&amp;nbsp;&lt;b&gt;Instituto Nacional de Enfermedades Neoplásicas&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: 14px; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: 9pt;"&gt;Marcia Motta, Substitute Director, Department of Science and Technology,&amp;nbsp;&lt;b&gt;Ministry of Health – Brazil&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: 14px; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: 9pt;"&gt;Luis Eduardo Johnson Rojas, Chief, Clinical Trials and Bioethics,&amp;nbsp;&lt;b&gt;Ministry of Health – Chile&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: 14px; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: 9pt;"&gt;Carlos E. Goicochea, M.D., Head, Clinical Operations,&amp;nbsp;&lt;b&gt;Pfizer-Perú&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: 14px; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: 9pt;"&gt;Eduardo Motti, M.D., Regional Head, Clinical Operations (So. Latin America),&amp;nbsp;&lt;b&gt;Pfizer&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: 14px; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: 9pt;"&gt;Fernanda Duran, M.D., Executive Director, Latin American Operations,&amp;nbsp;&lt;b&gt;PharmaNet&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: 14px; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: 9pt;"&gt;Andres Bayona, M.D., Associate Director, Clinical Management,&amp;nbsp;&lt;b&gt;PPD Perú&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: 14px; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: 9pt;"&gt;Daniel Ciriano, M.D., Medical Director,&lt;b&gt;&amp;nbsp;Roche Argentina&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: 14px; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: 9pt;"&gt;José Luiz Tavares, M.D., Ph.D., Head, Pharma Development Operations,&amp;nbsp;&lt;b&gt;Roche Brazil&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: 14px; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: 9pt;"&gt;Ernesto Huayta, M.D., Clinical Operations Head,&amp;nbsp;&lt;b&gt;sanofi-aventis Perú&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: 14px; margin-bottom: 6px; margin-left: 6px; margin-right: 6px; margin-top: 6px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: 9pt;"&gt;Francisco Garcia, Pharm.D., Regional Clinical Monitoring Manager, Study Management &amp;amp; Logistics,&amp;nbsp;&lt;/span&gt;&lt;b&gt;&lt;span style="font-size: 9pt;"&gt;Sanofi Pasteur Mexico&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;td align="left" valign="top"&gt;&lt;div align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt; margin-top: 10px;"&gt;&lt;span style="font-size: 11pt;"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="color: #028641; font-family: Arial;"&gt;Collaborate with Industry Colleagues, Regulators, Sites and CROs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size: 11pt;"&gt;&lt;/span&gt;&lt;span style="font-size: small;"&gt;&lt;hr style="background-color: #0d1c73;" /&gt;&lt;ul&gt;&lt;li&gt;&lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 10px; margin-left: -10px; margin-right: 15px; margin-top: 10px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: x-small;"&gt;Develop clinical trial protocols that are targeted and best suited for Latin American populations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 10px; margin-left: -10px; margin-right: 15px; margin-top: 10px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: x-small;"&gt;Collaborate with key stakeholders to promote clinical trials in Latin America&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 10px; margin-left: -10px; margin-right: 15px; margin-top: 10px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: x-small;"&gt;Evaluate a CROs processes and expertise to help reduce overall trial risk&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 10px; margin-left: -10px; margin-right: 15px; margin-top: 10px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: x-small;"&gt;Analyze ethical guidelines for drug access policies&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 10px; margin-left: -10px; margin-right: 15px; margin-top: 10px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: x-small;"&gt;Proactively prevent slowing down the clinical trial process by communicating with Latin American CROs and sites&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 10px; margin-left: -10px; margin-right: 15px; margin-top: 10px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: x-small;"&gt;Discuss the benefits of enacting investigative site standards&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 10px; margin-left: -10px; margin-right: 15px; margin-top: 10px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: x-small;"&gt;Assess the ROI of patient recruitment campaigns&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 10px; margin-left: -10px; margin-right: 15px; margin-top: 10px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: x-small;"&gt;Prevent patients lost-to-follow-up through increased clinical research education&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 10px; margin-left: -10px; margin-right: 15px; margin-top: 10px;"&gt;&lt;span style="color: black; font-family: Arial;"&gt;&lt;span style="font-size: x-small;"&gt;Efficiently ship material to and from study sites&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/li&gt;&lt;/ul&gt;&lt;div align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 10px; margin-right: 15px; margin-top: 10px;"&gt;&lt;a href="http://www.cbinet.com/referacolleague.cfm?ConfCode=PC10029"&gt;&lt;img border="0" height="142" src="http://www.cbinet.com/events/logos/Miscellaneous/PC10029_PostIt.gif" width="180" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;div align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 10px; margin-right: 15px; margin-top: 10px;"&gt;&lt;span style="font-family: Arial;"&gt;&lt;span style="font-size: x-small;"&gt;&lt;a href="http://www.linkedin.com/groups?gid=2888940&amp;amp;goback=.anh_2140387_1270143009134_1" target="_blank"&gt;&lt;img alt="" border="0" height="64" src="http://www.cbinet.com/events/logos/Miscellaneous/PC10112_LinkedIn.jpg" title="" width="144" /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table border="1" cellspacing="0" id="table21"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="middle" bgcolor="#000000" bordercolor="#028641" width="161"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px;"&gt;&lt;span style="color: white; font-family: Calibri;"&gt;&lt;span style="text-decoration: none;"&gt;&lt;span style="color: white; font-size: 11pt;"&gt;&lt;span style="font-weight: 700; text-decoration: none;"&gt;&lt;a href="http://www.cbinet.com/requestBrochure.cfm?confCode=PC10029&amp;amp;field=brochure"&gt;&lt;span style="color: white;"&gt;REQUEST BROCHURE&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td align="middle" bgcolor="#000000" bordercolor="#028641" width="120"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px;"&gt;&lt;span style="color: white; font-family: Calibri;"&gt;&lt;span style="text-decoration: none;"&gt;&lt;span style="color: white; font-size: 11pt;"&gt;&lt;span style="font-weight: 700; text-decoration: none;"&gt;&lt;a href="http://www.cbinet.com/show_conference.cfm?confCode=PC10029&amp;amp;field=conferencePricing"&gt;&lt;span style="color: white;"&gt;REGISTER&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td align="middle" bgcolor="#000000" bordercolor="#028641" width="155"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px;"&gt;&lt;span style="color: white; font-family: Calibri;"&gt;&lt;span style="text-decoration: none;"&gt;&lt;span style="color: white; font-size: 11pt;"&gt;&lt;span style="font-weight: 700; text-decoration: none;"&gt;&lt;a href="http://www.cbinet.com/show_conference.cfm?confCode=PC10029"&gt;&lt;span style="color: white;"&gt;VIEW WEBSITE&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td align="middle" bgcolor="#000000" bordercolor="#028641" width="146"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px;"&gt;&lt;b&gt;&lt;a href="http://www.cbinet.com/referacolleague.cfm?ConfCode=pc10029"&gt;&lt;span style="color: white; font-family: Calibri; font-size: 11pt;"&gt;REFER COLLEAGUES&lt;/span&gt;&lt;/a&gt;&lt;/b&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;br /&gt;&amp;nbsp;&lt;table border="0" cellpadding="0" cellspacing="0"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;div align="center"&gt;&lt;img src="http://www.cbinet.com/events/logos/Miscellaneous/PC10086_Sticky.gif" /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td width="331"&gt;&lt;div align="center" style="margin-bottom: 0px; margin-top: 0px;"&gt;&lt;span style="color: maroon; font-family: Calibri; font-size: 13pt; font-style: italic; font-weight: 700;"&gt;Advantage Pricing Offer:&lt;br /&gt;Register by July 16, 2010 to SAVE $300!*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;span style="font-size: small;"&gt;&lt;hr style="background-color: #0d1c73;" width="90%" /&gt;&lt;/span&gt;&lt;b&gt;&lt;i&gt;&lt;span style="font-family: Calibri; font-size: 11pt;"&gt;Registration Rates:&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;br /&gt;&lt;span style="font-family: Verdana;"&gt;&lt;/span&gt;&lt;table border="1" bordercolor="#000000" cellspacing="1"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center" bgcolor="#000000" width="177"&gt;&lt;span style="color: white; font-family: Verdana;"&gt;&lt;span style="font-size: 10pt;"&gt;Description&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td align="center" bgcolor="#800000" width="126"&gt;&lt;span style="color: white;"&gt;&lt;span style="font-size: 10pt;"&gt;Advantage Pricing&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td align="center" bgcolor="#800000"&gt;&lt;span style="color: white;"&gt;&lt;span style="font-size: 10pt;"&gt;Standard&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left" width="177"&gt;&lt;span style="font-family: Verdana;"&gt;&lt;span style="font-size: 10pt;"&gt;Pharmaceutical, Biotech,&lt;br /&gt;Medical Device Companies,&lt;br /&gt;Suppliers to Industry&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td align="center" width="126"&gt;&lt;span style="color: maroon; font-family: Verdana;"&gt;&lt;span style="font-size: 10pt;"&gt;$995*&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;span style="color: maroon; font-family: Verdana;"&gt;&lt;span style="font-size: 10pt;"&gt;$1295*&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left" width="177"&gt;&lt;span style="font-family: Verdana; font-size: 10pt;"&gt;Academics, Government Executives&lt;br /&gt;or Investigator Sites&lt;/span&gt;&lt;/td&gt;&lt;td align="center" width="126"&gt;&amp;nbsp;&lt;/td&gt;&lt;td align="center"&gt;&lt;span style="color: maroon; font-family: Verdana; font-size: 10pt;"&gt;$595*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;div style="margin-top: 0px;"&gt;&lt;span style="font-family: Calibri;"&gt;* +VAT Peru @ 19%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;center&gt;&lt;i&gt;&lt;span style="font-family: Calibri; font-size: 11pt;"&gt;&lt;b&gt;Sponsors:&lt;/b&gt;&lt;/span&gt;&lt;/i&gt;&lt;span style="font-family: Arial;"&gt;&lt;br /&gt;&lt;a href="http://www.incresearch.com/Global-Contract-Research-Organization.aspx"&gt;&lt;img border="0" height="88" src="http://www.cbinet.com/events/logos/I/Inc-Research.gif" width="108" /&gt;&lt;/a&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;a href="http://www.pharmanet.com/main/html/index.html"&gt;&lt;img border="0" height="41" src="http://www.cbinet.com/events/logos/P/PharmaNet-development-Grp.gif" width="202" /&gt;&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;a href="http://www.rxcompliancereport.com/"&gt;&lt;span style="text-decoration: none;"&gt;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/a&gt;&lt;a href="http://www.pharmainstitute.com/"&gt;&lt;span style="text-decoration: none;"&gt;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/a&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;a href="http://www.ppdi.com/"&gt;&lt;img border="0" height="44" src="http://www.cbinet.com/events/logos/P/PPD.gif" width="130" /&gt;&lt;/a&gt;&amp;nbsp;&lt;/span&gt;&lt;br /&gt;&lt;a href="http://www.marken.com/" target="_blank"&gt;&lt;img alt="" border="0" height="61" src="http://www.cbinet.com/events/logos/M/Marken.gif" title="" width="230" /&gt;&lt;/a&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;a href="http://dmvinternationaltranslations.com/" target="_blank"&gt;&lt;img alt="" border="0" height="96" src="http://www.cbinet.com/events/logos/D/DMV.gif" title="" width="180" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;i&gt;&lt;span style="font-family: Calibri; font-size: 11pt;"&gt;&lt;b&gt;&lt;br /&gt;Outstanding Support Provided by:&lt;/b&gt;&lt;/span&gt;&lt;/i&gt;&lt;br /&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&lt;a href="http://www.rxcompliancereport.com/"&gt;&lt;span style="text-decoration: none;"&gt;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/a&gt;&lt;a href="http://www.pharmainstitute.com/"&gt;&lt;span style="text-decoration: none;"&gt;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/a&gt;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;a href="http://www.rxcompliancereport.com/"&gt;&lt;span style="text-decoration: none;"&gt;&amp;nbsp;&lt;/span&gt;&lt;/a&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;br /&gt;&amp;nbsp;&lt;a href="http://www.eassertiva.com.br/"&gt;&lt;img border="0" height="58" src="http://www.cbinet.com/events/media_partners/A/Assertiva.gif" width="198" /&gt;&lt;/a&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;a href="http://www.scentryphar.com/"&gt;&lt;img border="0" height="88" src="http://www.cbinet.com/events/media_partners/S/Scentryphar.gif" width="194" /&gt;&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;a href="http://www.rxcompliancereport.com/"&gt;&lt;span style="text-decoration: none;"&gt;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/a&gt;&lt;a href="http://www.pharmainstitute.com/"&gt;&lt;span style="text-decoration: none;"&gt;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/a&gt;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;a href="http://www.rxcompliancereport.com/"&gt;&lt;span style="text-decoration: none;"&gt;&amp;nbsp;&lt;/span&gt;&lt;/a&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;br /&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/center&gt;&lt;center&gt;&lt;table border="1" cellspacing="0" id="table22"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="middle" bgcolor="#000000" bordercolor="#028641" width="161"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px;"&gt;&lt;span style="color: white; font-family: Calibri;"&gt;&lt;span style="text-decoration: none;"&gt;&lt;span style="color: white; font-size: 11pt;"&gt;&lt;span style="font-weight: 700; text-decoration: none;"&gt;&lt;a href="http://www.cbinet.com/requestBrochure.cfm?confCode=PC10029&amp;amp;field=brochure"&gt;&lt;span style="color: white;"&gt;REQUEST BROCHURE&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td align="middle" bgcolor="#000000" bordercolor="#028641" width="120"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px;"&gt;&lt;span style="color: white; font-family: Calibri;"&gt;&lt;span style="text-decoration: none;"&gt;&lt;span style="color: white; font-size: 11pt;"&gt;&lt;span style="font-weight: 700; text-decoration: none;"&gt;&lt;a href="http://www.cbinet.com/show_conference.cfm?confCode=PC10029&amp;amp;field=conferencePricing"&gt;&lt;span style="color: white;"&gt;REGISTER&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td align="middle" bgcolor="#000000" bordercolor="#028641" width="155"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px;"&gt;&lt;span style="color: white; font-family: Calibri;"&gt;&lt;span style="text-decoration: none;"&gt;&lt;span style="color: white; font-size: 11pt;"&gt;&lt;span style="font-weight: 700; text-decoration: none;"&gt;&lt;a href="http://www.cbinet.com/show_conference.cfm?confCode=PC10029"&gt;&lt;span style="color: white;"&gt;VIEW WEBSITE&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td align="middle" bgcolor="#000000" bordercolor="#028641" width="146"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px;"&gt;&lt;b&gt;&lt;a href="http://www.cbinet.com/referacolleague.cfm?ConfCode=pc10029"&gt;&lt;span style="color: white; font-family: Calibri; font-size: 11pt;"&gt;REFER COLLEAGUES&lt;/span&gt;&lt;/a&gt;&lt;/b&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;span style="font-family: Calibri; font-size: 11px; font-style: normal; font-variant: normal; font-weight: 700;"&gt;&lt;br /&gt;*Discount offer can not be combined with other discounts or applied to a current registration.&lt;br /&gt;Offer not valid on workshop only or academic registrations.&lt;/span&gt;&lt;b&gt;&lt;span style="font-family: Calibri; font-size: 11pt;"&gt;&lt;span style="color: #0d1c73;"&gt;&lt;a href="http://www.cbinet.com/LatinAmerica"&gt;&lt;span style="color: #028641;"&gt;www.cbinet.com/LatinAmerica&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style="color: #028641;"&gt;| 800-817-8601 |&amp;nbsp;&lt;/span&gt;&lt;a href="mailto:cbireg@cbinet.com"&gt;&lt;span style="color: #028641;"&gt;cbireg@cbinet.com&lt;/span&gt;&lt;/a&gt;&lt;span style="color: #028641;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/center&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/center&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-1366556063413320345?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/1366556063413320345/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=1366556063413320345' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/1366556063413320345'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/1366556063413320345'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2010/05/clinical-trials-in-latin-america_13.html' title='CLINICAL TRIALS IN LATIN AMERICA - SEPTEMBER 9-10,2010 * LIMA,PERU.'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-1790933271210055630</id><published>2010-05-06T16:55:00.002-03:00</published><updated>2010-06-14T13:07:14.952-03:00</updated><title type='text'>FOTOS DO EVENTO: III Workshop ACBIO-BR de Biodisponibilidade e Bioequivalência</title><content type='html'>&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;Confira as fotos do III&amp;nbsp;&lt;/span&gt;&lt;/b&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; font-family: 'Lucida Grande'; white-space: pre;"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;Workshop da ACBIO-BR,&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; font-family: 'Lucida Grande'; white-space: pre;"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;  realizado nos dias 07 e 08 de Junho em São Paulo.&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://4.bp.blogspot.com/_vqAAVB4XMoI/TBZSgeVK-4I/AAAAAAAAAAk/FwZmxFctjM0/s1600/IMG_0519.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="480" src="http://4.bp.blogspot.com/_vqAAVB4XMoI/TBZSgeVK-4I/AAAAAAAAAAk/FwZmxFctjM0/s640/IMG_0519.JPG" width="640" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://3.bp.blogspot.com/_vqAAVB4XMoI/TBZSLrXIRaI/AAAAAAAAAAU/FVobZzCccSc/s1600/IMG_0517.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="480" src="http://3.bp.blogspot.com/_vqAAVB4XMoI/TBZSLrXIRaI/AAAAAAAAAAU/FVobZzCccSc/s640/IMG_0517.JPG" width="640" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://1.bp.blogspot.com/_vqAAVB4XMoI/TBZSp6l9xqI/AAAAAAAAAAs/fkODv1AoDkQ/s1600/IMG_0520.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="480" src="http://1.bp.blogspot.com/_vqAAVB4XMoI/TBZSp6l9xqI/AAAAAAAAAAs/fkODv1AoDkQ/s640/IMG_0520.JPG" width="640" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://3.bp.blogspot.com/_vqAAVB4XMoI/TBZSLrXIRaI/AAAAAAAAAAU/FVobZzCccSc/s1600/IMG_0517.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;/a&gt;&lt;a href="http://2.bp.blogspot.com/_vqAAVB4XMoI/TBZSZZ2gSfI/AAAAAAAAAAc/WDdd8KC1XCk/s1600/IMG_0524.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="480" src="http://2.bp.blogspot.com/_vqAAVB4XMoI/TBZSZZ2gSfI/AAAAAAAAAAc/WDdd8KC1XCk/s640/IMG_0524.JPG" width="640" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://4.bp.blogspot.com/_vqAAVB4XMoI/TBZTeRlWTYI/AAAAAAAAAA0/On65bP6xJzo/s1600/IMG_0516.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="480" src="http://4.bp.blogspot.com/_vqAAVB4XMoI/TBZTeRlWTYI/AAAAAAAAAA0/On65bP6xJzo/s640/IMG_0516.JPG" width="640" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;Current and Future Perspectives about The Studies of Generics and&lt;br /&gt;Similar Medication&lt;br /&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: #444444;"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;June 07th and 08, 2010&amp;nbsp;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; font-family: 'Lucida Grande'; white-space: pre;"&gt;&lt;span class="Apple-style-span" style="color: #444444;"&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;in São Paulo, Brazil&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-size: x-large;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;b&gt;More Information:&lt;/b&gt;&lt;br /&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;br /&gt;&lt;a href="http://www.acbio.com.br/workshop1-english.htm"&gt;http://www.acbio.com.br/workshop1-english.htm&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Helvetica;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;blockquote type="cite"&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border-collapse: separate; font-family: Helvetica; font-size: medium; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border-collapse: separate; font-family: Helvetica; font-size: medium; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;"&gt;&lt;div background="back.jpg" bgcolor="#c0c0c0" leftmargin="0" marginheight="0" marginwidth="0" topmargin="0"&gt;&lt;div align="center"&gt;&lt;table border="0" cellpadding="0" cellspacing="0" id="table1" style="width: 600px;"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td bgcolor="#ffffff"&gt;&lt;div align="center"&gt;&lt;table border="0" cellpadding="0" cellspacing="0" id="table2"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;div align="center" class="MsoNormal" style="-webkit-background-clip: initial; -webkit-background-origin: initial; background-attachment: initial; background-color: white; background-image: initial; background-repeat: initial; line-height: normal; margin-bottom: 7.5pt;"&gt;&lt;span class="Apple-style-span" style="color: #163a87; font-family: Verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;b&gt;&lt;span style="color: #163a87; font-family: Verdana; font-size: x-small;"&gt;III Workshop ACBIO-BR de Biodisponibilidade e Bioequivalência&lt;br /&gt;Informações e preços nos links abaixo:&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;&lt;table border="1" bordercolordark="#000066" bordercolorlight="#000066" cellpadding="2" cellspacing="3" id="table32" style="border-collapse: collapse;"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td bgcolor="#000066"&gt;&lt;div align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 0pt;"&gt;&lt;span style="color: white; font-size: medium;"&gt;&lt;span style="font-family: Tahoma;"&gt;Programação&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;div align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 0pt;"&gt;&lt;br /&gt;&lt;span lang="PT-BR" style="font-family: Tahoma; font-weight: 700; line-height: 14px;"&gt;&lt;span style="color: #000066; font-size: medium;"&gt;07 – Junho-2010&lt;br /&gt;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;table border="1" bordercolordark="#000066" bordercolorlight="#000066" cellpadding="0" cellspacing="0" id="table33" style="border-collapse: collapse;"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="89"&gt;&lt;b&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 10pt; line-height: 14px;"&gt;Horário&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 10pt; line-height: 14px;"&gt;Tema (Assunto)&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 10pt; line-height: 14px;"&gt;Ministrante&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="29" width="89"&gt;&lt;span lang="PT-BR" style="color: black; font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;08:00 – 08:30 h&lt;/span&gt;&lt;/td&gt;&lt;td height="29"&gt;&lt;span lang="PT-BR" style="color: black; font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Credenciamento&lt;/span&gt;&lt;/td&gt;&lt;td height="29"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="89"&gt;&lt;span lang="PT-BR" style="color: black; font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;08:30 – 09:00 h&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span lang="PT-BR" style="color: black; font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Abertura dos trabalhos&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="89"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;09:00 – 09:45 h&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Panorama regulatório no Brasil para estudos de BD/BE&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Dirceu Raposo de Mello (a confirmar)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="89"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;09:45 – 10:30 h&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Visão do setor regulado: Panorama atual e desafios na condução de estudos de BD/BE&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Eduardo Abib Júnior (ACBIO)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="89"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;10:30 – 10:45 h&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;Coffee break&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="89"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;10:45 – 11:30 h&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Visão do patrocinador dos estudos de BD/BE&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;div class="MsoBodyText" style="text-align: justify;"&gt;&lt;span style="font-family: Calibri; font-size: 9pt;"&gt;Lauro D. Moretto (SINDUSFARMA)&lt;/span&gt;&lt;/div&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Luciano Maurício Lobo (PRO-GENÉRICOS)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="89"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;11:30 – 12:30 h&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Mesa redonda:&amp;nbsp;&lt;i&gt;Discussão a respeito dos temas abordados&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="89"&gt;&lt;b&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;12:30 – 14:00 h&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;Almoço&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="89"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;14:00 – 15:30 h&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;table border="0" bordercolordark="#000066" bordercolorlight="#000066" cellpadding="0" height="100%" id="table34" style="border-collapse: collapse;"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td height="30"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Estudos de BE com metodologias não-tradicionais (Métodos não-cromatográficos)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="30"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Estudos de BE com metodologias não-tradicionais (ICP-AES)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="30"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Visão regulatória no Brasil para métodos não cromatográficos&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;td&gt;&lt;table border="0" bordercolordark="#011d61" bordercolorlight="#011d61" cellpadding="0" id="table35" style="border-collapse: collapse;"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td height="30"&gt;&lt;span style="font-family: Calibri; font-size: 10pt; line-height: 14px;"&gt;Jeffrey Wuitschick (Laboratório Abbott) - a confirmar&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="30"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Flávio Leite (T&amp;amp;E Analítica)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="30"&gt;&lt;span style="font-family: Calibri; font-size: x-small;"&gt;&lt;span lang="EN-US" style="font-size: 9pt;"&gt;Ariadna Barra&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Arial; font-size: x-small;"&gt;&lt;span lang="EN-US" style="font-family: Calibri; font-size: 10pt;"&gt;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;(Anvisa)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="89"&gt;&lt;b&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;15:30 – 15:45 h&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Coffee Break&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="89"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;15:45 – 17:00 h&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;table border="0" height="100" id="table36"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td height="30"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Perspectivas da BE na America Latina&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="50"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Harmonização global das diretrizes para métodos bioanalíticos e análises de amostras biológicas&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="30"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Boas Práticas em Bioequivalência – Gerenciamento do SGQ&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;td&gt;&lt;table border="0" height="100" id="table37"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td height="30"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Maria Nella Gai&amp;nbsp; (Universidad de Chile -Facultad de Ciencias Quimicas Y Farmaceutica)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="50"&gt;&lt;span style="font-family: Calibri;"&gt;&lt;span lang="PT-BR" style="font-size: 9pt;"&gt;Fabio Garofolo (Bioanalytical Services, Algorithme Pharma Inc., Montreal- &amp;nbsp;Canada)&lt;/span&gt;&lt;/span&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Ariadna Barra (Anvisa)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="30"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Ticiana Moura (Sandoz do Brasil)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="89"&gt;&lt;b&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;17:00 h&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Coquetel de boas vindas&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;div align="center"&gt;&lt;span lang="PT-BR" style="font-family: Tahoma; font-weight: 700; line-height: 14px;"&gt;&lt;span style="color: #000066; font-size: medium;"&gt;&lt;br /&gt;&lt;br /&gt;08 – Junho-2010&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;table border="1" bordercolor="#000066" cellpadding="0" cellspacing="0" id="table38" style="border-collapse: collapse;"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;b&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 10pt; line-height: 14px;"&gt;Horário&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td width="328"&gt;&lt;b&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 10pt; line-height: 14px;"&gt;Tema (Assunto)&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td width="288"&gt;&lt;b&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 10pt; line-height: 14px;"&gt;Ministrante&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;span lang="PT-BR" style="color: black; font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;08:00 – 10:30 h&lt;/span&gt;&lt;/td&gt;&lt;td width="328"&gt;&lt;table border="0" id="table39"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td height="30"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Como tratar estudos de BE para fármacos de alta variabilidade&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="30"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Questões éticas envolvidas nos estudos de BE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="30"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Parâmetros clínicos e bioquímicos para consideração de voluntários sadios&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;td width="288"&gt;&lt;table border="0" id="table40"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td height="30"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Antônio Amarante (Mediana Consultoria)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="30"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Carmem Bertuzzo (Comitê de Ética - UNICAMP)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="30"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Gustavo Aguiar Campana (Formato Clínico)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;10:30 – 10:45 h&lt;/span&gt;&lt;/td&gt;&lt;td width="328"&gt;&lt;b&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Coffee break&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td width="288"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;10:45 – 12:30 h&lt;/span&gt;&lt;/td&gt;&lt;td width="328"&gt;&lt;table border="0" id="table41"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td height="40"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Visão da ANVISA para estudos com produtos oncológicos, BE de desenho diferenciado (fármacos de alta variabilidade)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="40"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Análise estatística e planos experimentais específicos de BE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="40"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Estudos de Farmacocinética e Farmacodinâmica no registro e renovação de medicamentos Similares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;td width="288"&gt;&lt;table border="0" id="table42"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td height="40"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Ariadna Barra (Anvisa)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="40"&gt;&lt;span style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Paula G. Strassmann (PGS/Medical Statistics)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td height="40"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Simoni Buranello (GC2- Pesquisa e Desenvolvimento de Produtos na&amp;nbsp;Área de Saúde&amp;nbsp;e Laboratório Central para Ensaios Clínicos)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;12:30 – 14:00 h&lt;/span&gt;&lt;/td&gt;&lt;td width="328"&gt;&lt;b&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Almoço&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td width="288"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;14:00 – 15:30 h&lt;/span&gt;&lt;/td&gt;&lt;td width="328"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Bioisenção e Equivalência Farmacêutica&lt;/span&gt;&lt;/td&gt;&lt;td width="288"&gt;&lt;div class="MsoBodyText" style="text-align: justify;"&gt;&lt;span style="font-family: Calibri;"&gt;&lt;span lang="PT-BR" style="font-size: 9pt;"&gt;Darja Grabnar-Peklar (LEK)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Ariadna Barra (Anvisa)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;15:30 – 15:45 h&lt;/span&gt;&lt;/td&gt;&lt;td width="328"&gt;&lt;b&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Coffee break&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td width="288"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;15:30 – 15:45 h&lt;/span&gt;&lt;/td&gt;&lt;td width="328"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Desenvolvimento e Validação de Testes de Dissolução no âmbito dos Centros de Equivalência Farmacêutica – Sugestão de um protocolo&lt;/span&gt;&lt;/td&gt;&lt;td width="288"&gt;&lt;div class="MsoBodyText" style="text-align: justify;"&gt;&lt;span style="font-family: Calibri;"&gt;&lt;span lang="PT-BR" style="font-size: 9pt;"&gt;Raquel Lima e Silva (&lt;/span&gt;&lt;/span&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Anvisa&lt;/span&gt;&lt;span style="font-family: Calibri;"&gt;&lt;span lang="PT-BR" style="font-size: 9pt;"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; font-weight: 700; line-height: 13px;"&gt;17:00 – 17:30 h&lt;/span&gt;&lt;/td&gt;&lt;td width="328"&gt;&lt;span lang="PT-BR" style="font-family: Calibri; font-size: 9pt; line-height: 13px;"&gt;Encerramento dos trabalhos&lt;/span&gt;&lt;/td&gt;&lt;td width="288"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;div align="center"&gt;&lt;table border="0" cellpadding="0" cellspacing="0" id="table47"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;table border="1" bordercolordark="#000066" bordercolorlight="#000066" cellpadding="2" cellspacing="3" id="table45" style="border-collapse: collapse;"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td bgcolor="#000066"&gt;&lt;div align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 0pt;"&gt;&lt;span style="color: white; font-size: large;"&gt;&lt;span style="font-family: Tahoma;"&gt;Informações e Inscrições&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table border="1" bordercolor="#c0c0c0" bordercolordark="#000066" bordercolorlight="#000066" cellpadding="2" cellspacing="3" id="table46"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;div align="center" class="MsoNormal" style="-webkit-background-clip: initial; -webkit-background-origin: initial; background-attachment: initial; background-color: white; background-image: initial; background-repeat: initial; line-height: normal; margin-bottom: 7.5pt;"&gt;&lt;b&gt;&lt;span lang="PT-BR" style="color: black; font-family: Arial;"&gt;&lt;br /&gt;Contatar:&lt;/span&gt;&lt;/b&gt;&lt;span lang="PT-BR" style="color: black; font-family: Arial;"&gt;&amp;nbsp; Elaine (Secretária)&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;b&gt;&lt;span lang="PT-BR" style="font-family: Arial;"&gt;Telefone:&amp;nbsp;&lt;/span&gt;&lt;/b&gt;&lt;span lang="PT-BR" style="font-family: Arial;"&gt;(19) 3231-8146&amp;nbsp;&amp;nbsp;&lt;b&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;Fax:&amp;nbsp;&lt;/b&gt;(19)&amp;nbsp;&lt;/span&gt;&lt;span style="font-family: Arial;"&gt;3235-2172&lt;/span&gt;&lt;span lang="PT-BR" style="font-family: Arial;"&gt;&lt;b&gt;&lt;br /&gt;E-mail:&amp;nbsp;&lt;/b&gt;&lt;a href="mailto:workshop@acbio.com.br" style="color: blue; text-decoration: underline;"&gt;workshop@acbio.com.br&lt;/a&gt;&lt;/span&gt;&lt;b&gt;&lt;span lang="PT-BR" style="color: black; font-family: Arial;"&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Helvetica;"&gt;&lt;span class="Apple-style-span" style="font-weight: normal;"&gt;&lt;span class="Apple-style-span" style="color: grey; font-family: Arial;"&gt;&lt;span class="Apple-style-span" style="font-size: large;"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;div align="center"&gt;&lt;div align="center"&gt;&lt;div style="-webkit-background-clip: initial; -webkit-background-origin: initial; background-attachment: initial; background-color: white; background-image: initial; background-repeat: initial; line-height: normal; margin-bottom: 7.5pt;"&gt;&lt;/div&gt;&lt;table border="1" bordercolordark="#000066" bordercolorlight="#000066" cellpadding="2" cellspacing="3" id="table51" style="border-collapse: collapse;"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td bgcolor="#000066"&gt;&lt;div align="left" class="MsoNormal" style="line-height: normal; margin-bottom: 0pt;"&gt;&lt;span style="color: white; font-size: medium;"&gt;&lt;span style="font-family: Tahoma;"&gt;ACBIO-BR -&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: white; font-family: Verdana; font-size: xx-small;"&gt;Associação Brasileira de Centros de Bioequivalência e Biodisponibilidade&lt;/span&gt;&lt;span style="font-family: Tahoma;"&gt;&lt;span style="color: white; font-size: medium;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: white; font-family: Tahoma; font-size: x-small;"&gt;Av. Andrade Neves, 295 - 18º ad. - Cj. 184 - Campinas - SP&lt;br /&gt;Fone: (19) 3231-8146&amp;nbsp; Fax: (19) 3235-2172&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;a href="http://www.acbio.com.br/" style="text-decoration: none;" target="_blank"&gt;&lt;span style="color: white;"&gt;www.acbio.com.br&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/span&gt;&lt;/blockquote&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="text-align: -webkit-center;"&gt;&lt;span class="Apple-style-span" style="color: white; font-family: Tahoma;"&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 3px; -webkit-border-vertical-spacing: 3px; border-collapse: collapse; font-size: large;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;table border="1" bordercolor="#000066" cellpadding="0" cellspacing="0" id="table57" style="border-collapse: collapse;"&gt;&lt;tbody&gt; &lt;/tbody&gt;&lt;/table&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-1790933271210055630?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/1790933271210055630/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=1790933271210055630' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/1790933271210055630'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/1790933271210055630'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2010/05/iii-workshop-acbio-br-of.html' title='FOTOS DO EVENTO: III Workshop ACBIO-BR de Biodisponibilidade e Bioequivalência'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://4.bp.blogspot.com/_vqAAVB4XMoI/TBZSgeVK-4I/AAAAAAAAAAk/FwZmxFctjM0/s72-c/IMG_0519.JPG' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-1983213265850955796</id><published>2010-04-25T19:35:00.000-03:00</published><updated>2010-04-25T19:35:34.462-03:00</updated><title type='text'>Desafios para a Saúde no Mundo Digital</title><content type='html'>&lt;span class="Apple-style-span" style="font-family: Helvetica;"&gt;Leia o artigo do Dr. Leonardo Diamante:&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.scribd.com/doc/29702666/Desafios-para-a-Saude-no-Mundo-Digital"&gt;http://www.scribd.com/doc/29702666/Desafios-para-a-Saude-no-Mundo-Digital&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-1983213265850955796?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/1983213265850955796/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=1983213265850955796' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/1983213265850955796'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/1983213265850955796'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2010/04/desafios-para-saude-no-mundo-digital.html' title='Desafios para a Saúde no Mundo Digital'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-886298446297420193</id><published>2010-04-10T09:57:00.000-03:00</published><updated>2010-04-10T09:57:25.207-03:00</updated><title type='text'>Genetic shock - Biotech firms and DNA patenting</title><content type='html'>&lt;span class="Apple-style-span" style="font-family: Verdana, sans-serif;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;h2 style="font-size: 0.9em; line-height: 21px; margin-bottom: 5px; margin-left: 0pt; margin-right: 0pt; margin-top: 0pt; padding-bottom: 0pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;"&gt;A surprising court ruling in America may loosen the drug industry’s grip on important genes:&lt;/h2&gt;&lt;div&gt;&lt;a href="http://www.economist.com/science-technology/displaystory.cfm?story_id=15810599"&gt;http://www.economist.com/science-technology/displaystory.cfm?story_id=15810599&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-886298446297420193?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/886298446297420193/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=886298446297420193' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/886298446297420193'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/886298446297420193'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2010/04/genetic-shock-biotech-firms-and-dna.html' title='Genetic shock - Biotech firms and DNA patenting'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-4774206370226901251</id><published>2010-04-10T09:45:00.000-03:00</published><updated>2010-04-10T09:45:52.363-03:00</updated><title type='text'>CFM vai emitir certificados digitais</title><content type='html'>&lt;a href="http://www.saudebusinessweb.com.br/noticias/index.asp?cod=67017&amp;amp;utm_source=newsletter_20100409&amp;amp;utm_medium=email&amp;amp;utm_content=CFM%20vai%20emitir%20certificados%20digitais&amp;amp;utm_campaign=SaudeBusinessWebNewsletter&amp;amp;__akacao=247969&amp;amp;__akcnt=4d5b2c27&amp;amp;__akvkey=0694"&gt;http://www.saudebusinessweb.com.br/noticias/index.asp?cod=67017&amp;amp;utm_source=newsletter_20100409&amp;amp;utm_medium=email&amp;amp;utm_content=CFM%20vai%20emitir%20certificados%20digitais&amp;amp;utm_campaign=SaudeBusinessWebNewsletter&amp;amp;__akacao=247969&amp;amp;__akcnt=4d5b2c27&amp;amp;__akvkey=0694&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-4774206370226901251?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/4774206370226901251/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=4774206370226901251' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/4774206370226901251'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/4774206370226901251'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2010/04/cfm-vai-emitir-certificados-digitais.html' title='CFM vai emitir certificados digitais'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-5834722093326736660</id><published>2010-03-31T05:41:00.000-03:00</published><updated>2010-03-31T05:41:45.286-03:00</updated><title type='text'>Drug Helps Diabetics, Trial Finds</title><content type='html'>Read:&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nytimes.com/2010/03/16/health/16diabetes.html?ref=research"&gt;http://www.nytimes.com/2010/03/16/health/16diabetes.html?ref=research&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-5834722093326736660?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/5834722093326736660/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=5834722093326736660' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/5834722093326736660'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/5834722093326736660'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2010/03/drug-helps-diabetics-trial-finds.html' title='Drug Helps Diabetics, Trial Finds'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-5770865123862969490</id><published>2010-03-14T17:11:00.000-03:00</published><updated>2010-03-14T17:11:26.001-03:00</updated><title type='text'>Avastin Fails Clinical Trial for Prostate Cancer</title><content type='html'>Read:&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nytimes.com/2010/03/13/business/13drug.html?ref=health"&gt;http://www.nytimes.com/2010/03/13/business/13drug.html?ref=health&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-5770865123862969490?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/5770865123862969490/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=5770865123862969490' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/5770865123862969490'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/5770865123862969490'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2010/03/avastin-fails-clinical-trial-for.html' title='Avastin Fails Clinical Trial for Prostate Cancer'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-5902250208204626744</id><published>2010-01-31T18:17:00.002-02:00</published><updated>2010-02-01T09:32:03.317-02:00</updated><title type='text'>Cancer and stem cells</title><content type='html'>&lt;span class="Apple-style-span" style="font-family: Verdana, sans-serif;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;h2 style="font-size: 0.9em; line-height: 21px; margin-bottom: 5px; margin-left: 0pt; margin-right: 0pt; margin-top: 0pt; padding-bottom: 0pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;"&gt;- More evidence that tumours, like healthy organs, grow from stem cells&lt;/h2&gt;&lt;div class="info" style="clear: both; color: #666666; font-size: 0.7em; line-height: 20px; margin-bottom: 13px; margin-left: 0pt; margin-right: 0pt; margin-top: 0pt; padding-bottom: 0pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;"&gt;Jan 14th 2010 |From&amp;nbsp;&lt;em style="margin-bottom: 0pt; margin-left: 0pt; margin-right: 0pt; margin-top: 0pt; padding-bottom: 0pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;"&gt;The Economist&lt;/em&gt;&lt;/div&gt;&lt;div class="info" style="clear: both; color: #666666; font-size: 0.7em; line-height: 20px; margin-bottom: 13px; margin-left: 0pt; margin-right: 0pt; margin-top: 0pt; padding-bottom: 0pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;"&gt;&lt;i&gt;&lt;a href="http://www.economist.com/sciencetechnology/displayStory.cfm?story_id=15268859"&gt;http://www.economist.com/sciencetechnology/displayStory.cfm?story_id=15268859&lt;/a&gt;&lt;/i&gt;&lt;/div&gt;&lt;div class="info" style="clear: both; color: #666666; font-size: 0.7em; line-height: 20px; margin-bottom: 13px; margin-left: 0pt; margin-right: 0pt; margin-top: 0pt; padding-bottom: 0pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;"&gt;&lt;i&gt;&lt;br /&gt;&lt;/i&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-5902250208204626744?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/5902250208204626744/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=5902250208204626744' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/5902250208204626744'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/5902250208204626744'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2010/01/cancer-and-stem-cells.html' title='Cancer and stem cells'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-8240078518740214910</id><published>2009-12-13T19:14:00.005-02:00</published><updated>2009-12-13T19:35:20.231-02:00</updated><title type='text'>IV Congresso Brasileiro de Telemedicina e Telessaúde e II Workshop do Laboratório de Excelência e Inovação em Telessaúde – América Latina e Europa.</title><content type='html'>&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;span style="font-family: 'Lucida Grande', Helvetica, sans-serif;"&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; white-space: pre;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0497-762832.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="240" src="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0497-762812.JPG" width="320" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;span style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; font-family: 'Lucida Grande', Helvetica, sans-serif; white-space: pre;"&gt; O IV Congresso Brasileiro de Telemedicina e Telessaúde &lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px; font-family: Arial, Helvetica, sans-serif; font-size: large; white-space: normal;"&gt;&amp;nbsp;ocorreu entre os dias 09 - 12 de Dezembro em Belo Horizonte.&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;span class="Apple-style-span" style="font-size: large;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;span class="Apple-style-span" style="font-size: large;"&gt;Mais informações através do link:&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: small;"&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Times; font-size: medium;"&gt;&lt;div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: 12px;"&gt;&lt;a href="http://www.telessaude2009.com.br/index.asp"&gt;http://www.telessaude2009.com.br/index.asp&lt;/a&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: small;"&gt;&lt;span style="font-size: 12px;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/Abertura_Workshop_9-de-dez-2009-516-725250.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="480" src="http://www.escolassertiva.com.br/blog/uploaded_images/Abertura_Workshop_9-de-dez-2009-516-725245.jpg" width="640" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: small;"&gt;&lt;span style="font-size: 12px;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;Saiba mais sobre o Programa Nacional de Telessaúde:&lt;/span&gt;&lt;br /&gt;&lt;div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;a href="http://www.telessaudebrasil.org.br/php/index.php"&gt;http://www.telessaudebrasil.org.br/php/ind&lt;/a&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0496-754638.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="480" src="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0496-754257.JPG" width="640" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;span style="font-family: Times;"&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;a href="http://www.medicina.ufmg.br/noticias/?p=9890" style="color: #1f497d; text-decoration: none;" target="_blank" title="blocked::http://www.medicina.ufmg.br/noticias/?p=9890"&gt;UFMG vai coordenar convênio do BID&amp;nbsp;&lt;/a&gt;&lt;a href="http://www.medicina.ufmg.br/noticias/?p=9890" style="color: #1f497d; text-decoration: none;" target="_blank" title="blocked::http://www.medicina.ufmg.br/noticias/?p=9890"&gt;na América Latina&lt;/a&gt;&amp;nbsp;- saiba mais:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&amp;nbsp;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&lt;a href="http://www.medicina.ufmg.br/noticias/?p=9890"&gt;http://www.medicina.ufmg.br/noticias/?p=9890&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: small;"&gt;&lt;span style="font-size: 12px;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.medicina.ufmg.br/noticias/?p=9845" rel="bookmark" style="color: #1f497d; text-decoration: none;" target="_blank" title="blocked::http://www.medicina.ufmg.br/noticias/?p=9845"&gt;Hélio Costa vem a BH para Congresso de Telessaúde&lt;/a&gt;&amp;nbsp;- saiba mais:&amp;nbsp;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0489-769564.JPG" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;span style="color: black; font-family: Arial, Helvetica, sans-serif; font-size: small;"&gt;&lt;span style="font-size: 12px;"&gt;&lt;span style="-webkit-text-decorations-in-effect: none;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="color: black; font-family: Arial, Helvetica, sans-serif; font-size: small;"&gt;&lt;a href="http://www.medicina.ufmg.br/noticias/?p=9845"&gt;http://www.medicina.ufmg.br/noticias/?p=9845&lt;/a&gt;&lt;/span&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0489-769564.JPG" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;span style="color: black; font-family: Arial, Helvetica, sans-serif; font-size: small;"&gt;&lt;span style="font-size: 12px;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: small;"&gt;&lt;span style="font-size: 12px;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: small;"&gt;&lt;span style="font-size: 12px;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: small;"&gt;&lt;span style="font-size: 12px;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: small;"&gt;&lt;span style="font-size: 12px;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: small;"&gt;&lt;span style="font-size: 12px;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: small;"&gt;&lt;span style="font-size: 12px;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: small;"&gt;&lt;span style="font-size: 12px;"&gt;&lt;div align="justify" style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0490-731409.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="400" src="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0490-731016.jpg" width="300" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: small;"&gt;&lt;span style="font-size: 12px;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;Confira também o evento realizado pela eAssertiva entre a ANVISA, CONEP e a RedBioética Latino America/UNESCO através do link: &lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;span style="font-family: 'Lucida Grande', Helvetica, sans-serif;"&gt;&lt;span style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; white-space: pre;"&gt; &lt;a href="http://www.escolassertiva.com.br/blog/2009_09_01_archive.html"&gt;http://www.escolassertiva.com.br/blog/2009_09_01_archive.html&lt;/a&gt; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: 'Lucida Grande', Helvetica, sans-serif;"&gt;&lt;span style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; white-space: pre;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: 'Lucida Grande', Helvetica, sans-serif;"&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; white-space: pre;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: 'Lucida Grande', Helvetica, sans-serif;"&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; white-space: pre;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: 'Lucida Grande', Helvetica, sans-serif;"&gt;&lt;span style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; white-space: pre;"&gt;Veja as fotos das reuniões clínicas transmitidas via internet:&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: 'Lucida Grande', Helvetica, sans-serif;"&gt;&lt;span style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; white-space: pre;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: 'Lucida Grande', Helvetica, sans-serif; font-size: small;"&gt;&lt;span style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; font-size: 13px; white-space: pre;"&gt;&lt;a href="http://www.escolassertiva.com.br/reunioes_clinicas.asp"&gt;&lt;span style="font-size: medium;"&gt;http://www.escolassertiva.com.br/reunioes_clinicas.asp&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size: medium;"&gt;&lt;br /&gt;&lt;/span&gt; &lt;/span&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-8240078518740214910?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/8240078518740214910/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=8240078518740214910' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/8240078518740214910'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/8240078518740214910'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2009/12/iv-congresso-brasileiro-de-telemedicina.html' title='IV Congresso Brasileiro de Telemedicina e Telessaúde e II Workshop do Laboratório de Excelência e Inovação em Telessaúde – América Latina e Europa.'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-4830109244659210836</id><published>2009-11-28T11:40:00.003-02:00</published><updated>2009-11-29T17:57:45.931-02:00</updated><title type='text'>Health Care Compliance</title><content type='html'>&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;Health Care Compliance -&amp;nbsp;HCC pode ser definido como uma categoria de regras de conduta e procedimentos que definem padrões éticos adotados nas interações entre fornecedores de produtos e serviços para a saúde e os profissionais da saúde.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;A eAssertiva, desenvolve projetos educacionias on line, para empresas que atuam em setores altamente regulados, de acordo com as necessidades In Company.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;A equipe da eAssertiva entende que projetos educacionais, criam diferenciais competitivos para as organizações, especialmente em uma sociedade baseada na economia do conhecimento e da inovação.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;Setores Altamente Regulados:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: large;"&gt;a) Educação médica.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial; font-size: medium;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial; font-size: medium;"&gt;&lt;div style="font: 24.0px 'Arial Narrow'; margin: 0.0px 0.0px 0.0px 0.0px;"&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;span style="font-size: medium;"&gt;b) Pesquisa.&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font: 24.0px 'Arial Narrow'; margin: 0.0px 0.0px 0.0px 0.0px;"&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;span style="font-size: medium;"&gt;c) Fabricação.&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font: 24.0px 'Arial Narrow'; margin: 0.0px 0.0px 0.0px 0.0px;"&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;span style="font-size: medium;"&gt;d) Serviços em geral para uma variedade de produtos para saúde.&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font: 24.0px 'Arial Narrow'; margin: 0.0px 0.0px 0.0px 0.0px;"&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;span style="font-size: medium;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font: 24.0px 'Arial Narrow'; margin: 0.0px 0.0px 0.0px 0.0px;"&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;span style="font-size: medium;"&gt;Mais informações sobre Projetos On Line In Company, podem ser solicitadas através do Serviço de Atendimento ao &amp;nbsp;Cliente: &amp;nbsp;sac@escolassertiva.com.br .&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;span class="Apple-style-span" style="font-size: large;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;span class="Apple-style-span" style="font-family: 'Trebuchet MS'; font-weight: bold; line-height: 27px;"&gt;&lt;span style="color: #444444;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;"Rede de Pesquisa Clínica quer dar chance ao SUS"&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;span class="Apple-style-span" style="font-size: large;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif;"&gt;&lt;span class="Apple-style-span" style="font-size: large;"&gt;&lt;a href="http://www.saudebusinessweb.com.br/noticias/index.asp?cod=63029&amp;amp;utm_source=newsletter_20091127&amp;amp;utm_medium=email&amp;amp;utm_content=&amp;amp;__akacao=205238&amp;amp;__akcnt=4d5b2c27&amp;amp;__akvkey=fcb6&amp;amp;utm_campaign=Sa%FAde+Business+Web+%2827%2F11%2F2009%29"&gt;http://www.saudebusinessweb.com.br/noticias/index.asp?cod=63029&amp;amp;utm_source=newsletter_20091127&amp;amp;utm_medium=email&amp;amp;utm_content=&amp;amp;__akacao=205238&amp;amp;__akcnt=4d5b2c27&amp;amp;__akvkey=fcb6&amp;amp;utm_campaign=Sa%FAde+Business+Web+%2827%2F11%2F2009%29&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-4830109244659210836?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/4830109244659210836/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=4830109244659210836' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/4830109244659210836'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/4830109244659210836'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2009/11/health-care-compliance.html' title='Health Care Compliance'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-4793111486683096859</id><published>2009-11-28T11:15:00.000-02:00</published><updated>2009-11-28T11:15:55.682-02:00</updated><title type='text'>Pharmacoeconomics: resultant perspective of decisions process</title><content type='html'>&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; font-family: 'Lucida Grande'; font-size: 13px; white-space: pre;"&gt;International Society for Pharmacoeconomics and Outcomes Research  &lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: 'Lucida Grande'; font-size: small;"&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; font-size: 13px; white-space: pre;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; font-family: Verdana; font-size: 11px;"&gt;&lt;span style="font-family: Verdana; font-size: 8.5pt; font-weight: bold;"&gt;&lt;a href="http://www.ispor.org/Events/Index.aspx?eventId=31" style="color: #055a90; font-family: Verdana; font-size: 9pt; text-decoration: none;"&gt;ISPOR 15th Annual International Meeting&lt;/a&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Verdana; font-size: 8.5pt;"&gt;&lt;b&gt;May 15-19, 2010&lt;br /&gt;&lt;/b&gt;Hilton Atlanta, Atlanta, GA, USA&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.ispor.org/Events/Index.aspx?eventId=31"&gt;http://www.ispor.org/Events/Index.aspx?eventId=31&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="font-family: Arial, Helvetica, sans-serif; font-size: 18px; font-style: italic;"&gt;O termo “farmacoeconomia” foi utilizado pela primeira vez apenas em 1986, por Townsed. No Brasil, Gabriela Tannus Branco de Araújo, economista formada pela FAAP – Fundação Armando Álvares Penteado –, curso de extensão em marketing pela ESPM – Escola Superior de Propaganda e Marketing – e presidente do capítulo Brasil da ISPOR – International Society for Pharmacoeconomics and Outcomes Research –, desenvolve amplo trabalho para a disseminação dessa ciência.&amp;nbsp;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: large;"&gt;&lt;span class="Apple-style-span" style="font-size: 18px;"&gt;&lt;i&gt;&lt;br /&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: large;"&gt;&lt;span class="Apple-style-span" style="font-size: 18px;"&gt;&lt;i&gt;&lt;span class="Apple-style-span" style="font-family: verdana, arial; font-size: large; font-style: normal; font-weight: bold;"&gt;Farmacoeconomia: perspectiva emergente no processo de tomada de decisão:&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana, arial;"&gt;&lt;span class="Apple-style-span" style="font-size: large;"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: large;"&gt;&lt;span class="Apple-style-span" style="font-size: 18px;"&gt;&lt;i&gt;&lt;a href="http://www.scielo.br/scielo.php?pid=S1413-81232005000500029&amp;amp;script=sci_arttext"&gt;http://www.scielo.br/scielo.php?pid=S1413-81232005000500029&amp;amp;script=sci_arttext&lt;/a&gt;&lt;br /&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-4793111486683096859?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/4793111486683096859/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=4793111486683096859' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/4793111486683096859'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/4793111486683096859'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2009/11/pharmacoeconomics-resultant-perspective.html' title='Pharmacoeconomics: resultant perspective of decisions process'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-7427115378016994797</id><published>2009-11-16T18:16:00.000-02:00</published><updated>2009-11-16T18:16:17.270-02:00</updated><title type='text'>Anvisa: Preço e tempo de registro de novos produtos</title><content type='html'>&lt;span style="color: #026d53; font-family: 'Trebuchet MS'; font-size: 18px; font-weight: bold; line-height: 19px;"&gt;Anvisa: Preço e tempo de registro de novos produtos&lt;/span&gt;&lt;br /&gt;&lt;span style="color: #026d53; font-family: 'Trebuchet MS'; font-size: large;"&gt;&lt;span style="font-size: 18px; line-height: 19px;"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color: #026d53; font-family: 'Trebuchet MS';"&gt;&lt;span style="line-height: 19px;"&gt;&lt;b&gt;&lt;a href="http://www.saudebusinessweb.com.br/noticias/index.asp?cod=62668&amp;amp;utm_source=newsletter_20091116&amp;amp;utm_medium=email&amp;amp;utm_content=ticker_Anvisa:%20Pre%C3%A7o%20e%20tempo%20de%20registro%20de%20novos%20produtos&amp;amp;utm_campaign=SaudeBusinessWebNewsletter"&gt;&lt;span style="font-size: small;"&gt;http://www.saudebusinessweb.com.br/noticias/index.asp?cod=62668&amp;amp;utm_source=newsletter_20091116&amp;amp;utm_medium=email&amp;amp;utm_content=ticker_Anvisa:%20Preço%20e%20tempo%20de%20registro%20de%20novos%20produtos&amp;amp;utm_campaign=SaudeBusinessWebNewsletter&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size: small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color: #026d53; font-family: 'Trebuchet MS'; font-size: 18px; font-weight: bold; line-height: 19px;"&gt;Laboratório Abbott aposta em inovação e pesquisa&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.saudebusinessweb.com.br/noticias/index.asp?cod=62674&amp;amp;utm_source=newsletter_20091116&amp;amp;utm_medium=email&amp;amp;utm_content=Laborat%C3%B3rio%20Abbott%20aposta%20em%20inova%C3%A7%C3%A3o%20e%20pesquisa&amp;amp;utm_campaign=SaudeBusinessWebNewsletter"&gt;&lt;span style="font-size: small;"&gt;http://www.saudebusinessweb.com.br/noticias/index.asp?cod=62674&amp;amp;utm_source=newsletter_20091116&amp;amp;utm_medium=email&amp;amp;utm_content=Laboratório%20Abbott%20aposta%20em%20inovação%20e%20pesquisa&amp;amp;utm_campaign=SaudeBusinessWebNewsletter&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size: small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size: small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: 'Trebuchet MS';"&gt;&lt;/span&gt;&lt;br /&gt;&lt;table border="0" cellpadding="0" cellspacing="0"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td class="texto_cinza_14" height="30" style="font-family: 'Trebuchet MS'; line-height: 14px;"&gt;&lt;span style="color: #38761d;"&gt;&lt;b&gt;Congresso mundial de hospitais discutiu o futuro da tecnologia na saúde&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="texto_cinza_14_noticia" style="color: #666666; font-family: 'Trebuchet MS'; font-size: 14px; line-height: 19px;"&gt;&lt;div id="text"&gt;&lt;div&gt;&lt;span style="color: black;"&gt;Entre os dias 9 e 12 de novembro aconteceu o 36º Congresso Mundial de Hospitais, realizado pela primeira vez no Brasil, na cidade do Rio de Janiero.&amp;nbsp;&lt;/span&gt;&lt;br /&gt;&lt;span style="color: black;"&gt;Saiba mais:&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&amp;gt; vídeo:&amp;nbsp;&lt;a href="http://www.saudebusinessweb.com.br/webcasts/index.asp?video=830"&gt;http://www.saudebusinessweb.com.br/webcasts/index.asp?video=830&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&amp;gt; Matéria:&amp;nbsp;&lt;a href="http://www.saudebusinessweb.com.br/noticias/index.asp?cod=62521"&gt;http://www.saudebusinessweb.com.br/noticias/index.asp?cod=62521&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-7427115378016994797?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/7427115378016994797/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=7427115378016994797' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/7427115378016994797'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/7427115378016994797'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2009/11/anvisa-preco-e-tempo-de-registro-de.html' title='Anvisa: Preço e tempo de registro de novos produtos'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-7662545545520352741</id><published>2009-11-12T03:46:00.000-02:00</published><updated>2009-11-12T03:46:25.858-02:00</updated><title type='text'>Collaborative Forum on Contracting for CROs</title><content type='html'>&lt;span class="Apple-style-span" style="font-family: Helvetica;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;div&gt;&amp;nbsp;&amp;nbsp;&lt;span style="color: #101010;"&gt;&amp;nbsp; &amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; font-family: 'Times New Roman', Times, serif; font-size: 16px;"&gt;&lt;span style="color: #101010;"&gt;December 2 - 3, 2009 -&amp;nbsp;Philadelphia, PA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&amp;nbsp;&amp;nbsp; &amp;nbsp; &amp;nbsp;&lt;a href="http://www.cbinet.com/show_conference.cfm?confCode=PC09089"&gt;http://www.cbinet.com/show_conference.cfm?confCode=PC09089&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-7662545545520352741?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/7662545545520352741/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=7662545545520352741' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/7662545545520352741'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/7662545545520352741'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2009/11/collaborative-forum-on-contracting-for.html' title='Collaborative Forum on Contracting for CROs'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-100610504533747173</id><published>2009-11-10T21:18:00.003-02:00</published><updated>2009-11-10T22:14:29.087-02:00</updated><title type='text'>Hospital Albert Einstein moderniza-se com aplicativo para iPhones/iPods touch</title><content type='html'>&lt;div&gt;&lt;span style="color: #026d53; font-family: 'Trebuchet MS'; font-size: x-large;"&gt;&lt;span style="font-size: 22px; line-height: 22px;"&gt;&lt;b&gt;eSaúde:&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color: #026d53; font-family: 'Trebuchet MS'; font-size: x-large;"&gt;&lt;span style="font-size: 22px; line-height: 22px;"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color: #026d53; font-family: 'Trebuchet MS'; font-size: 22px; font-weight: bold; line-height: 22px;"&gt;@ TI em Saúde: setor luta por mudanças de paradigma&lt;/span&gt;&lt;br /&gt;&lt;span class="Apple-style-span" style="color: #026d53; font-family: 'Trebuchet MS'; font-size: 22px; font-weight: bold; line-height: 22px;"&gt;&lt;a href="http://www.saudebusinessweb.com.br/noticias/index.asp?cod=62315&amp;amp;utm_source=newsletter_20091103&amp;amp;utm_medium=email&amp;amp;utm_content=TI%20em%20Sa%C3%BAde:%20setor%20luta%20por%20mudan%C3%A7as%20de%20paradigma&amp;amp;utm_campaign=SaudeBusinessWebNewsletter"&gt;&lt;span style="font-size: x-small;"&gt;http://www.saudebusinessweb.com.br/noticias/index.asp?cod=62315&amp;amp;utm_source=newsletter_20091103&amp;amp;utm_medium=email&amp;amp;utm_content=TI%20em%20Saúde:%20setor%20luta%20por%20mudanças%20de%20paradigma&amp;amp;utm_campaign=SaudeBusinessWebNewsletter&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; font-family: 'Lucida Grande'; font-size: 13px; white-space: pre;"&gt;@  &lt;span style="color: #38761d;"&gt;&lt;span style="font-size: x-large;"&gt;Aplicativo para iPhones/iPods touch&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;span style="color: #505050; font-family: Helvetica, Arial, Verdana, sans-serif; font-size: 13px; line-height: 22px;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color: #505050; font-family: Helvetica, Arial, Verdana, sans-serif; font-size: 13px; line-height: 22px;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color: #505050; font-family: Helvetica, Arial, Verdana, sans-serif; font-size: 13px; line-height: 22px;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color: #505050; font-family: Helvetica, Arial, Verdana, sans-serif; font-size: 13px; line-height: 22px;"&gt;&lt;div style="border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: inherit; font-size: 13px; font-style: inherit; font-weight: inherit; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; line-height: 1.5em; margin-bottom: 15px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"&gt;&lt;a href="http://macmagazine.uol.com.br/wp-content/uploads/2009/11/07-einstein.png" rel="shadowbox[post-76694];player=img;" style="border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: black; font-family: inherit; font-size: 13px; font-style: inherit; font-weight: inherit; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; line-height: 1.5em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: underline;"&gt;&lt;img alt="Einstein Mobile no iPod touch" class="alignright size-medium wp-image-76695" height="511" src="http://macmagazine.uol.com.br/wp-content/uploads/2009/11/07-einstein-247x511.png" style="border-bottom-width: 0px; border-color: initial; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; display: inline; float: right; font-family: inherit; font-size: 13px; font-style: inherit; font-weight: inherit; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; line-height: inherit; margin-bottom: 5px; margin-left: 12px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;" title="Einstein Mobile no iPod touch" width="247" /&gt;&lt;/a&gt;Este não é um aplicativo que interessará diretamente à comunidade usuária de iPhones/iPods touch, mas nos interessa no sentido de mostrar o quanto a plataforma móvel da Apple tem crescido não só internacional, mas também nacionalmente, adentrando os mais diversos segmentos. Foi lançado hoje na App Store o Einstein Mobile, o aplicativo oficial para médicos do conceituado&amp;nbsp;&lt;a href="http://macmagazine.uol.com.br/out.php?url=http://www.einstein.br/" style="border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: black; font-family: inherit; font-size: 13px; font-style: inherit; font-weight: inherit; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; line-height: 1.5em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: underline;" target="_blank"&gt;Hospital Albert Einstein&lt;/a&gt;, de São Paulo.&lt;br /&gt;&lt;/div&gt;&lt;div style="border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: inherit; font-size: 13px; font-style: inherit; font-weight: inherit; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; line-height: 1.5em; margin-bottom: 15px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"&gt;O acesso ao&amp;nbsp;&lt;em style="border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: inherit; font-size: 13px; font-style: italic; font-weight: inherit; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; line-height: 1.5em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"&gt;app&lt;/em&gt;&amp;nbsp;é restrito, pois ele proporciona acesso móvel a informações clínicas e cirúrgicas do Einstein, sendo direcionado, portanto, aos profissionais que trabalham por lá.&lt;br /&gt;&lt;/div&gt;&lt;div style="border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: inherit; font-size: 13px; font-style: inherit; font-weight: inherit; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; line-height: 1.5em; margin-bottom: 15px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"&gt;O sistema do Einstein Mobile inclui acesso a informações de pacientes (resultados de exames, passagens, prescrições de medicamentos e contatos), cadastros médicos (CRM, especialidade e contatos), recurso de comunicação entre pacientes e médicos do corpo clínico do Einstein (via SMS, email ou ligações), visualização da agenda cirúrgica e consulta integrada ao CID 10 (Classificação Internacional de Doenças).&lt;br /&gt;&lt;/div&gt;&lt;div style="border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: inherit; font-size: 13px; font-style: inherit; font-weight: inherit; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; line-height: 1.5em; margin-bottom: 15px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"&gt;Aos médicos do hospital, o Einstein Mobile já está&lt;a href="http://macmagazine.uol.com.br/out.php?url=http://itunes.apple.com/us/app/einstein-mobile/id337461205?mt=8" style="border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: black; font-family: inherit; font-size: 13px; font-style: inherit; font-weight: inherit; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; line-height: 1.5em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: underline;" target="_blank"&gt;disponível gratuitamente na App Store&lt;/a&gt;&amp;nbsp;(2,7MB). Ele requer o firmware 3.0 ou superior de iPhones/iPods touch e foi desenvolvido pela empresa baiana&amp;nbsp;&lt;a href="http://macmagazine.uol.com.br/?s=%22MTM+Tecnologia%22" style="border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: black; font-family: inherit; font-size: 13px; font-style: inherit; font-weight: inherit; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; line-height: 1.5em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: underline;"&gt;MTM Tecnologia&lt;/a&gt;.&lt;br /&gt;&lt;/div&gt;&lt;div style="border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: inherit; font-size: 13px; font-style: inherit; font-weight: inherit; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; line-height: 1.5em; margin-bottom: 15px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"&gt;Fonte:Macmagazine&lt;br /&gt;&lt;/div&gt;&lt;div style="border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: inherit; font-size: 13px; font-style: inherit; font-weight: inherit; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; line-height: 1.5em; margin-bottom: 15px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"&gt;&lt;span style="font-size: 11px; font-weight: bold; line-height: 22px;"&gt;por&amp;nbsp;&lt;a href="http://macmagazine.uol.com.br/author/admin/" style="border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: black; font-family: inherit; font-size: 11px; font-style: inherit; font-weight: inherit; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none;" title="Posts de Rafael Fischmann"&gt;Rafael Fischmann&lt;/a&gt;&amp;nbsp;| 07/11/2009&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size: small;"&gt;&lt;span style="font-size: 11px; line-height: 22px;"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size: small;"&gt;&lt;span style="font-size: 11px; line-height: 22px;"&gt;&lt;b&gt;&lt;span style="font-size: 13px; font-weight: normal;"&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size: small;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size: small;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size: small;"&gt;&lt;b&gt;&lt;h2 class="title" style="border-bottom-width: 1px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-color: rgb(226, 226, 226); border-top-style: solid; border-top-width: 3px; font-family: inherit; font-style: inherit; font-weight: bold; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; letter-spacing: -0.05em; line-height: 1em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 6px; padding-left: 0px; padding-right: 0px; padding-top: 6px;"&gt;&lt;span style="font-size: x-large;"&gt;&lt;span style="color: black;"&gt;&lt;span style="background-color: white;"&gt;@ Aplicativo para iPhone diagnosticará doenças pela tosse&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/h2&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size: small;"&gt;&lt;span style="font-size: 11px; line-height: 22px;"&gt;&lt;b&gt;&lt;a href="http://macmagazine.uol.com.br/2009/11/10/aplicativo-para-iphone-diagnosticara-doencas-pela-tosse/"&gt;http://macmagazine.uol.com.br/2009/11/10/aplicativo-para-iphone-diagnosticara-doencas-pela-tosse/&lt;/a&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="sexy-bookmarks sexy-bookmarks-bg-sexy" style="background-image: url(http://macmagazine.uol.com.br/wp-content/plugins/sexybookmarks/images/sexy-trans.png) !important; background-position-x: 0%; background-position-y: -348px !important; background-repeat: no-repeat !important; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; clear: both !important; display: block !important; font-family: inherit; font-size: 13px; font-style: inherit; font-weight: inherit; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; height: 29px; line-height: 1.5em; margin-bottom: 0px !important; margin-left: 0px !important; margin-right: 0px !important; margin-top: 20px !important; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px !important; padding-left: 10px !important; padding-right: 0px !important; padding-top: 25px !important;"&gt;&lt;ul class="socials" style="-webkit-background-clip: initial !important; -webkit-background-origin: initial !important; background-attachment: initial !important; background-color: transparent !important; background-image: none !important; background-position: initial initial !important; background-repeat: initial !important; border-bottom-style: none !important; border-bottom-width: 0px !important; border-color: initial !important; border-color: initial; border-left-style: none !important; border-left-width: 0px !important; border-right-style: none !important; border-right-width: 0px !important; border-style: initial; border-top-style: none !important; border-top-width: 0px !important; float: left !important; font-family: inherit; font-size: 13px; font-style: inherit; font-weight: inherit; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; line-height: inherit; list-style-image: initial; list-style-position: initial; list-style-type: none; margin-bottom: 0px !important; margin-left: 0px !important; margin-right: 0px !important; margin-top: 0px !important; outline-color: initial !important; outline-style: none !important; outline-width: 0px !important; padding-bottom: 0px !important; padding-left: 0px !important; padding-right: 0px !important; padding-top: 0px !important; width: 560px;"&gt;&lt;li class="sexy-twitter" style="-webkit-background-clip: initial !important; -webkit-background-origin: initial !important; background-attachment: initial !important; background-color: transparent !important; background-image: url(http://macmagazine.uol.com.br/wp-content/plugins/sexybookmarks/images/sexy-sprite.png) !important; background-position-x: -490px !important; background-position-y: 100%; background-repeat: no-repeat !important; border-bottom-style: none !important; border-bottom-width: 0px !important; border-color: initial !important; border-color: initial; border-left-style: none !important; border-left-width: 0px !important; border-right-style: none !important; border-right-width: 0px !important; border-style: initial; border-top-style: none !important; border-top-width: 0px !important; clear: none !important; cursor: pointer !important; display: inline !important; float: left !important; font-family: inherit; font-size: 13px; font-style: inherit; font-weight: inherit; font: normal normal normal 100%/normal Helvetica, Arial, Verdana, sans-serif; height: 29px !important; line-height: 1.5em; list-style-image: initial; list-style-position: initial; list-style-type: none !important; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial !important; outline-style: none !important; outline-width: 0px !important; padding-bottom: 0px !important; padding-left: 0px !important; padding-right: 0px !important; padding-top: 0px !important; width: 60px !important;"&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&lt;/span&gt;&lt;span style="font-family: 'Lucida Grande'; font-size: small;"&gt;&lt;span style="font-size: 11px;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-100610504533747173?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/100610504533747173/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=100610504533747173' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/100610504533747173'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/100610504533747173'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2009/11/hospital-albert-einstein-moderniza-se.html' title='Hospital Albert Einstein moderniza-se com aplicativo para iPhones/iPods touch'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-1803818831616415659</id><published>2009-11-07T11:01:00.007-02:00</published><updated>2009-11-07T19:29:37.504-02:00</updated><title type='text'>PEP 2009</title><content type='html'>&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/Photo-on-2009-11-06-at-15.57-738260.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="300" src="http://www.escolassertiva.com.br/blog/uploaded_images/Photo-on-2009-11-06-at-15.57-738257.jpg" width="400" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;A eAssertiva esteve presente no PEP 2009, evento realizado nos dias 04 - 06 de Novembro de 2009 no Instituto de Ensino e Pesquisa Hospital Sírio-Libanês na cidade de São Paulo.&lt;br /&gt;&lt;br /&gt;O evento desse ano, com certeza representou um marco para o setor da eSaúde no Brasil, pois notamos avanços importantes nas discussões em torno da unificação de padrões e do envolvimento de autoridades &amp;nbsp; como a presença do Sr. Rogério Sugai do Ministério da Saúde, &amp;nbsp;que falou sobre os projetos governamentais e o RES para o Brasil e da Dra. Ana Estella Haddad, DEGETS do Ministério da Saúde abordando o tema: O Projeto Nacional de Telessaúde.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/Photo-on-2009-11-06-at-14.36-709452.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;img border="0" height="240" src="http://www.escolassertiva.com.br/blog/uploaded_images/Photo-on-2009-11-06-at-14.36-709280.jpg" width="320" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;O evento também contou com a presença de palestrantes internacionais de grande relevância no cenário da informática médica: Leslie Lenert, National Center for Public Health Informatics (NCPHI), Centers for Disease Control and Prevention - CDC, Estados Unidos. &lt;br /&gt;&lt;br /&gt;A experiência do NHS na implantação do RES - Mike Bainbridge - National Health System - NHS, Inglaterra.&lt;br /&gt;&lt;br /&gt;A contribuição da Fundação OpenEHR para o RES - Thomas Beale - Fundação OpenEHR, Austrália&lt;br /&gt;&lt;br /&gt;O papel da ICPC no RES - Michael S. Klinkman, University of Michigan, Estados Unidos.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/4-up-on-2009-11-06-at-15.59-740818.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="480" src="http://www.escolassertiva.com.br/blog/uploaded_images/4-up-on-2009-11-06-at-15.59-740815.jpg" width="640" /&gt;&lt;/a&gt;&lt;a href="http://www.blogger.com/post-edit.g?blogID=1548128325933368660&amp;amp;postID=1803818831616415659"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;Confira a Programação Completa do evento abaixo e o link para o blog sobre tecnologia, saúde e temas diversos:&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;span style="font-family: Helvetica;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;blockquote type="cite"&gt;&lt;span style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border-collapse: separate; font-family: Helvetica; font-size: medium; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;"&gt;&lt;span style="font-family: Georgia, serif; font-size: 15px;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/blockquote&gt;&lt;a href="http://www.blogger.com/%3Ca%20href=%22http://ldiamante.blogspot.com/%22%3Ehttp://ldiamante.blogspot.com/%3C/a%3E"&gt;&lt;/a&gt;&lt;a href="http://ldiamante.blogspot.com/"&gt;http://ldiamante.blogspot.com/&lt;/a&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;span style="font-family: Arial, arial; font-size: 15px;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;blockquote&gt;&lt;div align="center" class="western" lang="pt-BR" style="page-break-before: always;"&gt;&lt;span style="font-family: arial, helvetica, sans-serif; font-size: small;"&gt;&lt;b&gt;Programação Científica&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;br /&gt;&lt;span style="font-family: arial, helvetica, sans-serif; font-size: small;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;table align="center" border="1" bordercolor="#000000" cellpadding="5" cellspacing="0" style="width: 806px;"&gt;&lt;colgroup&gt;&lt;/colgroup&gt;&lt;tbody&gt;&lt;/tbody&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td bgcolor="#e0e0e0" height="9" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="72"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="color: navy; font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Data&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#e0e0e0" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="color: navy; font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Hora&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#e0e0e0" colspan="2" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="627"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="color: navy; font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Atividade&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#e0e0e0" colspan="4" height="23" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="794"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="color: navy; font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Quarta-feira, 04 de Novembro&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#e0e0e0" height="14" rowspan="7" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="72"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span style="color: navy;"&gt;&lt;span lang="pt-BR"&gt;&lt;b&gt;0&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: navy;"&gt;&lt;span lang="pt-BR"&gt;&lt;b&gt;4/11&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="color: navy; font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Quarta&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#efefff" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;8:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;9:00h&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#efefff" colspan="2" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="627"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;b&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Inscrições&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;9:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;-&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;1200h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="278"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;b&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Tutorial 1&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Por onde começar na implantação de um PEP?&lt;/b&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Lincoln de Assis Moura Jr - ZILICS, SP&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Cláudio Giulliano Alves da Costa - SBIS, SP&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="339"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;b&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Tutorial 2&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Padrões para o RES: HL7 e Arquétipos&lt;/b&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Marivan Santiago Abrahão - HL7 Brasil, SP&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Sérgio Miranda Freire - UERJ, RJ&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#efefff" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;12:00h 14:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#efefff" colspan="2" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="627"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Intervalo para Almoço&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;14:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;-&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;17:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="278"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;b&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Tutorial 3&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span lang="pt-BR"&gt;&lt;b&gt;Aspectos Legais de um PEP: Certificação de Software e Assinatura Eletrônica&lt;/b&gt;&lt;/span&gt;&lt;span lang="pt-BR"&gt;&lt;b&gt;&amp;nbsp;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Marcelo Lúcio da Silva - SBIS, SP&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Stanley Galvão - SBIS, SP&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Luis Gustavo Kiatake - e-Val, SP&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="339"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;b&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Tutorial 4&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Arquitetura Integrada para o RES&lt;/b&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Beatriz de Faria Leão - ZILICS, SP&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Fabiane Bizinella Nardon - ZILICS, SP&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#eaf1dd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;18:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#eaf1dd" colspan="2" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="627"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;b&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Abertura do PEP'2009&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;18:30&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;-&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;19:15h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#ffffdd" colspan="2" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="627"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span lang="pt-BR"&gt;&lt;b&gt;Conferência C#01:&lt;/b&gt;&lt;/span&gt;&lt;span lang="pt-BR"&gt;&amp;nbsp;&lt;/span&gt;&lt;span lang="pt-BR"&gt;&lt;b&gt;O Registro Eletrônico em Saúde - depois de 40 anos - onde estamos?&amp;nbsp;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span lang="en-US"&gt;Conferencista&lt;/span&gt;&lt;span lang="en-US"&gt;:&amp;nbsp;&lt;/span&gt;&lt;span lang="en-US"&gt;&lt;b&gt;Mike Bainbridge, NHS, Inglaterra&lt;/b&gt;&lt;/span&gt;&lt;span lang="pt-BR"&gt;&amp;nbsp;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Coordenação:&amp;nbsp;&lt;b&gt;Beatriz de Faria Leão&amp;nbsp;&lt;/b&gt;- ZILICS, SP&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#efefff" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;19:30h&lt;br /&gt;21:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#efefff" colspan="2" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="627"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;b&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Coquetel de Confraternização&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;div align="left" class="western" lang="pt-BR" style="page-break-before: always;"&gt;&lt;br /&gt;&lt;span style="font-family: arial, helvetica, sans-serif; font-size: small;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;table align="center" border="1" bordercolor="#000000" cellpadding="5" cellspacing="0" style="width: 799px;"&gt;&lt;colgroup&gt;&lt;/colgroup&gt;&lt;tbody&gt;&lt;/tbody&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td bgcolor="#e0e0e0" colspan="4" height="23" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="794"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="color: navy; font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Quinta-feira, 05 de Novembro&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#e0e0e0" height="161" rowspan="10" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="72"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span style="color: navy;"&gt;&lt;span lang="pt-BR"&gt;&lt;b&gt;0&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: navy;"&gt;&lt;span lang="pt-BR"&gt;&lt;b&gt;5/11&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="color: navy; font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Quinta&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;9:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;-&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;10:30h&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#ffffdd" colspan="2" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="627"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;b&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Painel P#01: Experiências com o PEP/RES&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Neste painel serão apresentadas experiências na implantação de Prontuário Eletrônico do Paciente por instituições públicas e privadas, hospitais e governo. Também serão apresentados casos práticos na implantação de certificação digital.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span style="color: black;"&gt;&lt;b&gt;A experiência do Hospital Sírio Libanês - Margareth Ortiz&amp;nbsp;&lt;/b&gt;&lt;/span&gt;&lt;span style="color: black;"&gt;- Hospital Sírio Libânes,SP&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span style="color: black;"&gt;&lt;b&gt;O RES "sem-papel" - José Ricardo Guimarães&lt;/b&gt;&lt;/span&gt;&lt;span style="color: black;"&gt;&amp;nbsp;- Hospital de Clínicas de Porto Alegre (HCPA), RS&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span style="color: black;"&gt;&lt;b&gt;O papel do RES nas operadoras de planos de saúde - Antônio Pompílio&lt;/b&gt;&lt;/span&gt;&lt;span style="color: black;"&gt;&amp;nbsp;- Unimed Campinas, SP&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span style="color: black;"&gt;Moderador:&amp;nbsp;&lt;/span&gt;&lt;span style="color: black;"&gt;&lt;b&gt;Luciano Lima&lt;/b&gt;&lt;/span&gt;&lt;span style="color: black;"&gt;&amp;nbsp;- Rede Sarah de Hospitais Reabilitação, BH&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#efefff" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="en-US"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;10:30h 11:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#efefff" colspan="2" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="627"&gt;&lt;div align="center" class="western" lang="en-US"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Coffee Break&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#eaf1dd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="en-US"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;11:00h&lt;br /&gt;-&lt;br /&gt;11:30h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#eaf1dd" colspan="2" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="627"&gt;&lt;div align="center" class="western" lang="en-US"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Sessão Empresas I -&amp;nbsp;&lt;strong&gt;SERASA&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="en-US"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Utilizando Certificação Digital no Prontuário Eletrônico - Case Hospital Português Pernambuco&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="en-US"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Palestrante : Dr. Antonio Prado&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="en-US"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;11:30h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="en-US"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;-&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="en-US"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;12:30h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#ffffdd" colspan="2" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="627"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span lang="en-US"&gt;&lt;b&gt;Conferência&lt;/b&gt;&lt;/span&gt;&lt;span lang="en-US"&gt;&lt;b&gt;&amp;nbsp;C#02&lt;/b&gt;&lt;/span&gt;&lt;span lang="en-US"&gt;:&amp;nbsp;&lt;/span&gt;&lt;span lang="en-US"&gt;&lt;b&gt;O papel da TI na Saúde Pública&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span lang="en-US"&gt;Conferencista&lt;/span&gt;&lt;span lang="en-US"&gt;&lt;b&gt;: Leslie Lenert,&amp;nbsp;&lt;/b&gt;&lt;/span&gt;&lt;span lang="en-US"&gt;National Center for Public Health Informatics (NCPHI), Centers for Disease Control and Prevention&lt;/span&gt;&lt;span lang="en-US"&gt;&amp;nbsp;- CDC, Estados Unidos&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;a href="http://www.blogger.com/post-edit.g?blogID=1548128325933368660&amp;amp;postID=1803818831616415659" name="OLE_LINK1" style="color: black; text-decoration: none;"&gt;&lt;/a&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span lang="pt-BR"&gt;Coordenação:&amp;nbsp;&lt;/span&gt;&lt;span lang="pt-BR"&gt;&lt;b&gt;Heimar de Fátima Marin&lt;/b&gt;&lt;/span&gt;&lt;span lang="pt-BR"&gt;, UNIFESP,SP&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#efefff" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;12:30h&lt;br /&gt;14:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#efefff" colspan="2" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="627"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Intervalo para Almoço&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;14:00h&lt;br /&gt;-&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;15:30h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#ffffdd" colspan="2" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="627"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Painel P#02:&lt;/b&gt;&lt;span style="color: black;"&gt;&lt;b&gt;&amp;nbsp;Blocos construtores do RES: como implementar?&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Para o desenvolvimento de um RES, é fundamental a definição da sua arquitetura, com seus componentes e os chamados blocos construtores. Este painel apresentará os diferentes blocos construtores do RES.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Terminologias Clínicas - Jussara Macedo Pinho Rotzsch&lt;/b&gt;&amp;nbsp;- DIDES - Agência Nacional de Saúde Suplementar - ANS, RJ&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;A experiência do NHS na implantação do RES - Mike Bainbridge&lt;/b&gt;&amp;nbsp;- National Health System - NHS, Inglaterra&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;A contribuição da Fundação OpenEHR para o RES&lt;/b&gt;&amp;nbsp;-&amp;nbsp;&lt;strong&gt;Thomas Beale&lt;/strong&gt;&amp;nbsp;- Fundação OpenEHR, Austrália&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;strong&gt;O papel da ICPC no RES&lt;/strong&gt;&amp;nbsp;-&amp;nbsp;&lt;strong&gt;Michael S. Klinkman&lt;/strong&gt;, University of Michigan, Estados Unidos.&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span style="color: black;"&gt;Moderador:&amp;nbsp;&lt;/span&gt;&lt;span style="color: black;"&gt;&lt;b&gt;Lincoln de Assis Moura Jr,&amp;nbsp;&lt;/b&gt;&lt;/span&gt;&lt;span style="color: black;"&gt;ZILICS, SP&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#efefff" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;15:30h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;16:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#efefff" colspan="2" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="627"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Coffee Break&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#eaf1dd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="en-US"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;16:00h 16:30h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#eaf1dd" colspan="2" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="627"&gt;&lt;div align="center" class="western" lang="en-US"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Sessão Empresas II -&amp;nbsp;&lt;strong&gt;INTERSYSTEMS&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="en-US"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Experiência Inovadora do uso do prontuário eletrônico em Hospital de&lt;br /&gt;grande porte com corpo clinico aberto&amp;nbsp;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="en-US"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Convidada: Luciana Macedo, Gerente de TI do Hospital Português&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;16:30h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;-&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;18:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#ffffdd" colspan="2" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="627"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Painel P#03:&lt;/b&gt;&lt;span style="color: black;"&gt;&lt;b&gt;&amp;nbsp;&lt;/b&gt;&lt;/span&gt;&lt;b&gt;Projetos governamentais para o Registro Eletrônico em Saúde (RES)&lt;/b&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Em todo o mundo, vários países, estados e cidades estão planejando e/ou implantando projetos de RES, com o intuito de interligar as suas instituições de saúde, compartilhando informações clínicas dos cidadãos. Este painel pretende apresentar experiências nacionais e internacionais em projetos de RES na área governamental.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;O projeto de RES do Estado de Minas Gerais - Rodrigo Queiroga&lt;/b&gt;&amp;nbsp;- SES-MG, MG&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;A experiência de implantação do SIGA Saúde - Moacyr Perche&lt;/b&gt;&amp;nbsp;- SMS Campinas, SP&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;RES para o Brasil - Rogério Sugai&amp;nbsp;&lt;/b&gt;- Ministério da Saúde, DF&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span style="color: black;"&gt;Moderador:&lt;/span&gt;&lt;span style="color: black;"&gt;&lt;b&gt;&amp;nbsp;Marco Antônio Gutierrez&lt;/b&gt;&lt;/span&gt;&lt;span style="color: black;"&gt;&amp;nbsp;- INCOR, SP&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#eaf1dd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;18:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;20:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#eaf1dd" colspan="2" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="627"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;b&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Assembléia Geral Ordinária - SBIS&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;div align="left" class="western" lang="pt-BR" style="page-break-before: always;"&gt;&lt;br /&gt;&lt;span style="font-family: arial, helvetica, sans-serif; font-size: small;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;table align="center" border="1" bordercolor="#000000" cellpadding="5" cellspacing="0" style="width: 799px;"&gt;&lt;colgroup&gt;&lt;/colgroup&gt;&lt;tbody&gt;&lt;/tbody&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td bgcolor="#e0e0e0" colspan="3" height="22" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="787"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="color: navy; font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Sexta-feira, 06 de Novembro&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#e0e0e0" height="182" rowspan="7" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="72"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="color: navy; font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;06/11&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="color: navy; font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Sexta&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;9:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;-&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;10:30h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="620"&gt;&lt;h3 align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif; font-size: small;"&gt;Painel P#04: Recursos Humanos para a área de Informática em Saúde&lt;/span&gt;&lt;/h3&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Obter sucesso na implantação de um PEP depende de vários fatores, dentre os quais profissionais capacitados no projeto, desenvolvimento e implantação de sistemas de informação em saúde. Para isso, é fundamental a formação e capacitação de especialista na área. Este painel irá debater quais as estratégias o Brasil deve adotar para a formação desse tipo de profissional.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;A experiência de PG da UNIFESP - Heimar de Fátima Marin&lt;/b&gt;&amp;nbsp;- UNIFESP, SP&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;O programa de graduação em Informática em Saúde da USP-RP - Evandro Seron Ruiz&lt;/b&gt;&amp;nbsp;- USP-Ribeirão Preto, SP&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;O programa de informática em saúde do Hospital Italiano - Fernán Quirós&amp;nbsp;&lt;/b&gt;- Hospital Italiano de Buenos Aires, Argentina&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;O Programa de Informática em Saúde do Centro Nacional de Informática em Saúde Pública - Leslie Lenert&lt;/b&gt;&amp;nbsp;-&lt;/span&gt;&lt;span style="font-size: small;"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span style="font-size: 11pt;"&gt;&amp;nbsp;&lt;/span&gt;&lt;span lang="en-US"&gt;Centers for Disease Control and Prevention&lt;/span&gt;&lt;span lang="pt-BR"&gt;, Estados Unidos&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Moderador:&amp;nbsp;&lt;b&gt;Daniel Sigulem&lt;/b&gt;&amp;nbsp;- DIS/UNIFESP, SP&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#efefff" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;10:30h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;11:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#efefff" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="620"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Coffee break&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#eaf1dd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;11:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;11:30h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#eaf1dd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="620"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Sessão&amp;nbsp;&lt;strong&gt;SBIS&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: Arial;"&gt;O que é a SBIS? Quais os projetos? Como participar?&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;11:30&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;-&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;12:30h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="620"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span lang="en-US"&gt;&lt;b&gt;Conferência&lt;/b&gt;&lt;/span&gt;&lt;span lang="en-US"&gt;&lt;b&gt;&amp;nbsp;C#03&lt;/b&gt;&lt;/span&gt;&lt;span lang="en-US"&gt;:&amp;nbsp;&lt;/span&gt;&lt;span lang="en-US"&gt;&lt;b&gt;FEMI Saúde Digital: um Projeto Nacional de Registro Eletrônico em Saúde do Uruguai&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span lang="en-US"&gt;Conferencista:&amp;nbsp;&lt;/span&gt;&lt;span lang="en-US"&gt;&lt;b&gt;Alvaro Margolis,&amp;nbsp;&lt;/b&gt;&lt;/span&gt;&lt;span lang="en-US"&gt;IMIA-LAC, Uruguai&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span lang="en-US"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;span lang="pt-BR"&gt;Coordenação:&amp;nbsp;&lt;/span&gt;&lt;span lang="pt-BR"&gt;&lt;b&gt;Ivan Torres Pisa,&lt;/b&gt;&lt;/span&gt;&lt;span lang="pt-BR"&gt;&amp;nbsp;UNIFESP, SP&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#efefff" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;12:30h&lt;br /&gt;14:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#efefff" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="620"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Intervalo para Almoço&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;14:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;-&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;16:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#ffffdd" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="620"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Painel P#05: RES - Como transformar o sonho em realidade?&lt;/b&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Considerando que o PEP/RES é realmente uma necessidade, o desafio é como tornar o sonho em realidade. Para apresentar e debater como realizar essa transformação, este painel contará com a presença de instituições para apresentar tendências, projetos e inovações em PEP/RES.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;Quais os padrões necessários? - Márcia Marinho&lt;/b&gt;&amp;nbsp;- Comissão Especial de Estudos em Informática em Sáude, ABNT&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;O papel do DATASUS no projeto nacional - Francisco José Marques&amp;nbsp;&lt;/b&gt;- DATASUS/MS, DF&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;a href="http://www.blogger.com/post-edit.g?blogID=1548128325933368660&amp;amp;postID=1803818831616415659" name="OLE_LINK2" style="color: black; text-decoration: none;"&gt;&lt;/a&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;O médico na era digital: o que muda? -&amp;nbsp;Gerson Zafalon&lt;/b&gt;&amp;nbsp;- Conselho Federal de Medicina, DF&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;O Projeto Nacional de Telessaúde - Ana Estella Haddad&amp;nbsp;&lt;/b&gt;- DEGETS Ministério da Saúde, DF&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Moderador:&amp;nbsp;&lt;span style="color: black;"&gt;&lt;b&gt;Cláudio Giulliano Alves da Costa,&amp;nbsp;&lt;/b&gt;&lt;/span&gt;&lt;span style="color: black;"&gt;SBIS, SP&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor="#e1ffe1" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="76"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;16:00h&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;td bgcolor="#e1ffe1" style="color: black; font-family: Arial, arial; font-size: 11pt;" width="620"&gt;&lt;div align="center" class="western" lang="pt-BR"&gt;&lt;b&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;Sessão de Encerramento&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: -webkit-center;"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/blockquote&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;span style="font-family: Arial, arial; font-size: 15px;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center" class="western" lang="pt-BR" style="page-break-before: always;"&gt;&lt;span style="font-family: arial, helvetica, sans-serif;"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.blogger.com/post-edit.g?blogID=1548128325933368660&amp;amp;postID=1803818831616415659"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-1803818831616415659?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/1803818831616415659/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=1803818831616415659' title='5 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/1803818831616415659'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/1803818831616415659'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2009/11/pep-2009.html' title='PEP 2009'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>5</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-8781310181214353665</id><published>2009-11-06T14:12:00.002-02:00</published><updated>2009-11-06T14:15:14.516-02:00</updated><title type='text'>A Place Where Cancer Is the Norm</title><content type='html'>&lt;a href="http://www.nytimes.com/2009/10/25/health/research/25anderson.html?_r=1&amp;ref=health"&gt;http://www.nytimes.com/2009/10/25/health/research/25anderson.html?_r=1&amp;ref=health&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Research Uproar at a Cancer Clinic&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nytimes.com/2009/10/23/business/23carle.html?ref=research"&gt;http://www.nytimes.com/2009/10/23/business/23carle.html?ref=research&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-8781310181214353665?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/8781310181214353665/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=8781310181214353665' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/8781310181214353665'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/8781310181214353665'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2009/11/place-where-cancer-is-norm_06.html' title='A Place Where Cancer Is the Norm'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-1874101207627979568</id><published>2009-09-29T15:49:00.031-03:00</published><updated>2009-11-07T17:42:18.698-02:00</updated><title type='text'>Projeto WikiMeeting em Pesquisa Clínica - 2009</title><content type='html'>O segundo WikiMeeting em Pesquisa Clínica, com representantes da ANVISA,  CONEP e UNESCO ocorreu no dia 19 de Setembro de 2009 em São Paulo.&lt;br /&gt;&lt;br /&gt;&lt;b&gt;&lt;span style="font-size: x-large;"&gt;Assista os vídeos através do link:&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;a href="http://www.escolassertiva.com.br/"&gt;&lt;b&gt;&lt;span style="font-size: x-large;"&gt;www.escolassertiva.com.br&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: auto;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: auto;"&gt;&lt;span style="font-family: Verdana, Arial, Helvetica, sans-serif;"&gt;&lt;b&gt;&lt;span style="color: #666666;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;img src="http://www.escolassertiva.com.br/img/filmadora_EAD.gif" /&gt;&amp;nbsp;Assista o vídeo:&amp;nbsp;&lt;/span&gt;&lt;a href="http://www.escolassertiva.com.br/informativo.asp?vAcao=ArquivoDigital" target="_blank"&gt;&lt;span style="color: #666666;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;Contribuição da ANVISA sobre os avanços no cenário da Pesquisa Clínica no Brasil&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&amp;nbsp;- Dr. Alessandro Ferreira do Nascimento - Coordenação de Pesquisas e Ensaios Clínicos - COPEM/GESEF/Gerência Geral de Medicamentos - GGMED.&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;hr /&gt;&lt;b&gt;&lt;span style="color: #666666;"&gt;&amp;nbsp;&lt;img src="http://www.escolassertiva.com.br/img/filmadora_EAD.gif" /&gt;&amp;nbsp;Assista o vídeo:&amp;nbsp;&lt;a href="http://www.escolassertiva.com.br/informativo.asp?vAcao=ArquivoDigital" target="_blank"&gt;&lt;span style="color: #666666;"&gt;Contribuição da CONEP sobre os avanços no cenário da Pesquisa Clínica no Brasil&lt;/span&gt;&lt;/a&gt;&amp;nbsp;- Dr. Dalton L. de Paula Ramos.&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;hr /&gt;&lt;b&gt;&lt;span style="color: #666666;"&gt;&amp;nbsp;&lt;img src="http://www.escolassertiva.com.br/img/filmadora_EAD.gif" /&gt;&amp;nbsp;Assista o vídeo:&amp;nbsp;&lt;a href="http://www.escolassertiva.com.br/informativo.asp?vAcao=ArquivoDigital" target="_blank"&gt;&lt;span style="color: #666666;"&gt;Vunerabilidade dos sujeitos de pesquisa e registro de investigadores&lt;/span&gt;&lt;/a&gt;&amp;nbsp;- Dra.Patrícia Saidon da RedBioética/Latino Americana/UNESCO da Argentina.&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: auto;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0439-739821.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="300" src="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0439-739645.JPG" width="400" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;Sobre os participantes:&lt;br /&gt;&lt;br /&gt;&amp;gt; Abertura e boas vindas dos facilitadores - Dr. Moisés Vanunci, Dr. Paulo Antoline e o Sr. Edgar Baptista.&lt;br /&gt;&lt;br /&gt;&amp;gt; Vunerabilidade dos sujeitos de pesquisa e registro de investigadores - Dra.Patrícia Saidon da RedBioética/Latino Americana/UNESCO da Argentina.&lt;br /&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0427-714443.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="300" src="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0427-714275.JPG" width="400" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&amp;gt; Contribuição da ANVISA sobre os avanços no cenário da Pesquisa Clínica no Brasil –  Dr. Alessandro  Ferreira do Nascimento - Coordenação de Pesquisas e Ensaios Clínicos – COPEM/GESEF/Gerência Geral de Medicamentos – GGMED.&lt;br /&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0421-754361.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="300" src="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0421-754199.JPG" width="400" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&amp;gt; Contribuição da CONEP sobre os avanços no cenário da Pesquisa Clínica no Brasil - Dr. Dalton L. de Paula Ramos.&lt;br /&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0048-744082.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="300" src="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0048-743645.JPG" width="400" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&amp;gt;  Contribuição dos  Centros de Pesquisa e da Associação dos Centros de Bioequivalência (ACBIO)  – Sra. Marci Pietrocola, Dr. Eduardo Abib (Presidente da Associação dos Centros de Bioequivalência), Dra. Mineko Tominaga, Dr. José Segalla (Presidente da Sociedade Brasileira de Oncologia Clínica).&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&amp;gt; Contribuição dos representantes de CEPs. - Dr. Hudson Buck, Sra. Teresa Cristina D. C. Nascimento.&lt;br /&gt;&lt;br /&gt;&amp;gt; Contribuição das Indústrias Farmacêuticas - Sr. Luciano Lobo(Pró-Genéricos), Sra. Camila Paschoalato, Sra.Juliana Tosta, Dr Lênio Alvarenga, Dra. Laura Luchini.  &lt;br /&gt;&lt;br /&gt;&amp;gt; Contribuição das CROs e Convidados – Dra. Cecília Lorenzi (Eurotrials)  Dr. Rodrigo Spricigo (GCdois), Sra. Isabela Drummond (Fundação Biominas).&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0040-753080.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="320" src="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0040-752664.JPG" width="320" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Pontos de discussões:&lt;br /&gt;&lt;br /&gt;VULNERABILIDADE DOS SUJEITOS DE PESQUISA E REGISTRO DOS INVESTIGADORES – RedBioética Latino Americana UNESCO.&lt;br /&gt;&lt;br /&gt;Dra. Patrícia Saidon - Argentina.&lt;br /&gt;&lt;br /&gt;Comentário sobre RedBioética:&lt;br /&gt;&lt;br /&gt;Promover EAD em ética clínica&lt;br /&gt;Publicações&lt;br /&gt;Situação da América Latina – evolução da legislação em bioética&lt;br /&gt;Aumento da participção nos últimos 15 anos.&lt;br /&gt;Aumento de CROs na AL&lt;br /&gt;Aumento de CEPs&lt;br /&gt;Resultado da criação de medidas regulatórias&lt;br /&gt;A proteção do sujeito como um dever do estado&lt;br /&gt;As normas devem contemplar:&lt;br /&gt;As pesquisas devem priorizar desafios locais à saúde.&lt;br /&gt;Características sócio-cultural ds sujeitos&lt;br /&gt;TCLE – características especiais em cada situação vulnerável&lt;br /&gt;Estímulo à formação de CEPs – estruturar o  funcionamento e composição&lt;br /&gt;Custos: de que forma o voluntários terão acesso ao benefícios obtidos com a pesquisa&lt;br /&gt;Conflito de interesse – registro de ensaios clínicos:&lt;br /&gt;Interesse do investigador diferente do sujeito – contrário à Helsinque e Nuremberg&lt;br /&gt;Interesse individual&lt;br /&gt;Interesse patrocinador x investigador.&lt;br /&gt;Instituições de saúde x investigadores/patrocinadores&lt;br /&gt;Conflitos na publicação.&lt;br /&gt;Autores fantasmas – não participaram de nada&lt;br /&gt;Autores convidados – dar nome de peso ao artigo&lt;br /&gt;Recomendações de editores de grandes revistas:&lt;br /&gt;Autores participantes.&lt;br /&gt;Publicação de resutados negativos.&lt;br /&gt;Transparência de conflitos.&lt;br /&gt;Publicação somente de ensaios registrados&lt;br /&gt;Quem deve ser registrado:&lt;br /&gt;Clinical trials – não obrigatório&lt;br /&gt;Registro on-line não público&lt;br /&gt;Experiências em registro:&lt;br /&gt;Argentina – informações públicas:&lt;br /&gt;Contém: data, patrocinador, CRO, todas as instituições, contato de todos (patrocinadores, investigadores) países participantes, estado atual de inclusão, qual o objeto e estudo, que tipo de estudo, protocolo, tam de amostra, comissões que apreciaram, aprovações de CEPs, emendas de protocolo.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0437-736555.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="240" src="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0437-736389.JPG" width="320" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;CONTRIBUIÇÃO DA ANVISA SOBRE OS AVANÇOS NO CENÁRIO DA PESQUISA CLÍNICA NO BRASIL&lt;br /&gt;Dr. Alessandro Ferreira - Brasil.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Vê a contribuição como contundente e colaborativo para tornar o país atrativo.&lt;br /&gt;Situação da ANVISA:&lt;br /&gt;Duas vertentes: seg e efic/ técnico-farmacêutica&lt;br /&gt;Apresentação do organograma novo relativo à fármacos e estudos clínicos.&lt;br /&gt;Construção de um guia de estudos não-clínicos – diretrizes sem força de lei.&lt;br /&gt;Faz parte de uma agenda regulatória – publicações de diretrizes para estudos e registro.&lt;br /&gt;Estas publicações visam informação sem necessidade de alteração de leis e normas oficiais. &lt;br /&gt;Publicação IN04/2008 – Boas Práticas Clínicas&lt;br /&gt;Baseado em documentos internacionais – documento das Américas. &lt;br /&gt;Norteia inspeções com caráter educativo.&lt;br /&gt;POP é o caminho para aplicação de GCP.&lt;br /&gt;Assumiu como objetivo a diminuição do passivo administrativo&lt;br /&gt;Reuniões para avaliação de protocolos&lt;br /&gt;Comprometimento responsável em acelerar a apreciação dos processos&lt;br /&gt;Balanço da RDC 39 &lt;br /&gt;Histórico, desvinculo da apreciação da CONEP, mas há intenso intercâmbio entre eles.&lt;br /&gt;Exigência de registro em bases de dados internacionais de estudos de fase III&lt;br /&gt;Pontuou aspectos que geram atraso na apreciação de processos&lt;br /&gt;Notivisa – relato de eventos adversos, adaptação para pesquisa clínica em andamento – prazo: fim do ano.&lt;br /&gt;Acesso expandido e uso compassivo (RDC28): norma em elaboração.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0039-793733.JPG" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;img border="0" height="240" src="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0039-793294.JPG" width="320" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;CONTRIBUIÇÃO DA CONEP SOBRE OS AVANÇOS NO CENÁRIO DA PESQUISA CLÍNICA NO BRASIL&lt;br /&gt;Dr. Dalton Ramos - Brasil.&lt;br /&gt;&lt;br /&gt;III Encep – Plataforma Brasil&lt;br /&gt;Retomar a vocação dos CEPs e da CONEP – &lt;br /&gt;Manter a ciência a serviço da pessoa. &lt;br /&gt;604 CEPs ativos em abril de 2009.&lt;br /&gt;16 Comitês fechados pela CONEP em 2008&lt;br /&gt;Brasil como referência internacional em pesquisa – acarreta na demanda de maior profissionalismo. &lt;br /&gt;Dois grandes temas: &lt;br /&gt;Aspectos operacionais&lt;br /&gt;Comunicação: sinais de ineficiência – trabalho em papel...&lt;br /&gt;Abertura para expressão – conciliação com o tamanho do sistema.&lt;br /&gt;A descentralização é necessária, mas no momento não é a realidade. &lt;br /&gt;Os CEPs solicitam a não-descentralização por receio de desamparo.&lt;br /&gt;Investimento nas bases de comunicação – SISNEP. 1/3 dos CEP não são nem cadastrados no sisnep. &lt;br /&gt;Demandas de controle social e pesquisas envolvendo o SUS.&lt;br /&gt;É necessária integração efetiva com a ANVISA. Existem duplicidades de exigências que serão unificadas por bases compatíveis.&lt;br /&gt;ENCEP também com finalidade de qualificação dos CEPs.     &lt;br /&gt;Alta rotatividade de técnicos integrantes da CONEP.&lt;br /&gt;Número de protocolos para análise – busca pela descentralização.&lt;br /&gt;Aumento de qualidade nos protocolos de pesquisa acompanhou o desenvolvimento da pesquisa.&lt;br /&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0433-773619.JPG" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;img border="0" height="240" src="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0433-773454.JPG" width="320" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Aplicação e interpretação das normas nacionais&lt;br /&gt;Workshops para determinação de aspectos técnicos.&lt;br /&gt;Evolução da ciência - dinamismo do sistema&lt;br /&gt;Maiores dificuldades:TCLE &lt;br /&gt;Envolvimento do pesquisador principal: traduções malfeitas que colocam em dúvida o envolvimento do pesquisador. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Adaptação à realidade local do TCLE&lt;br /&gt;Efetiva avaliação de risco-benefício também deve seguir a realidade local&lt;br /&gt;As propostas internacionais podem ter viés em relação aos países menos desenvolvidos. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0041-763345.JPG" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="300" src="http://www.escolassertiva.com.br/blog/uploaded_images/IMG_0041-762913.JPG" width="400" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-1874101207627979568?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/1874101207627979568'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/1874101207627979568'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2009/09/projeto-wikimeeting-em-pesquisa-clinica.html' title='Projeto WikiMeeting em Pesquisa Clínica - 2009'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-8677741869918513890</id><published>2009-09-04T13:26:00.000-03:00</published><updated>2009-09-04T13:27:32.806-03:00</updated><title type='text'>AIDS vaccines</title><content type='html'>AIDS&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.economist.com/sciencetechnology/displayStory.cfm?story_id=14350119"&gt;http://www.economist.com/sciencetechnology/displayStory.cfm?story_id=14350119&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Antibiotics&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.economist.com/sciencetechnology/displayStory.cfm?story_id=14350129"&gt;http://www.economist.com/sciencetechnology/displayStory.cfm?story_id=14350129&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-8677741869918513890?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/8677741869918513890/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=8677741869918513890' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/8677741869918513890'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/8677741869918513890'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2009/09/aids-vaccines.html' title='AIDS vaccines'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-8726348273776729021</id><published>2009-08-25T21:06:00.001-03:00</published><updated>2009-08-25T21:08:30.755-03:00</updated><title type='text'>eAssertiva is using Twitter - Cursos On Line !!</title><content type='html'>witter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What are you doing? Join today to start receiving assertiva's tweets.&lt;br /&gt;&lt;br /&gt;&lt;a href="https://twitter.com/assertiva#/assertiva"&gt;https://twitter.com/assertiva#/assertiva&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-8726348273776729021?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/8726348273776729021/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=8726348273776729021' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/8726348273776729021'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/8726348273776729021'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2009/08/eassertiva-is-using-twitter-cursos-on.html' title='eAssertiva is using Twitter - Cursos On Line !!'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-6261806728560402808</id><published>2009-08-10T20:17:00.001-03:00</published><updated>2009-08-10T20:27:53.038-03:00</updated><title type='text'>Brazilian Registry of Clinical Trials (Rebrac): strengthening of clinical trials management in Brazil</title><content type='html'>Registro Brasileiro de Ensaios Clínicos (Rebrac)&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.scielosp.org/scielo.php?pid=S0034-89102009000200024&amp;script=sci_arttext"&gt;http://www.scielosp.org/scielo.php?pid=S0034-89102009000200024&amp;script=sci_arttext&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Clinical trials registry platform&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.scielo.br/scielo.php?pid=S1516-84842007000200001&amp;script=sci_arttext"&gt;http://www.scielo.br/scielo.php?pid=S1516-84842007000200001&amp;script=sci_arttext&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-6261806728560402808?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/6261806728560402808/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=6261806728560402808' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/6261806728560402808'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/6261806728560402808'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2009/08/brazilian-registry-of-clinical-trials.html' title='Brazilian Registry of Clinical Trials (Rebrac): strengthening of clinical trials management in Brazil'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-7622991607389819648</id><published>2009-08-06T19:48:00.000-03:00</published><updated>2009-08-06T19:50:10.759-03:00</updated><title type='text'>Como Funciona o Aprendizado Online</title><content type='html'>por Lee Ann Obringer - traduzido por HowStuffWorks Brasil&lt;br /&gt;&lt;br /&gt;        &lt;a href="http://informatica.hsw.uol.com.br/aprendizado-online.htm/printable"&gt;http://informatica.hsw.uol.com.br/aprendizado-online.htm/printable&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Os Dez Mandamentos do Aluno On-Line em Pesquisa Clínica&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;1. Acesso à Internet: ter endereço eletrônico, um provedor e um equipamento adequado é pré-requisito para a participação nos cursos a distância.&lt;br /&gt;2. Habilidade e disposição para operar programas: ter conhecimentos básicos de Informática é necessário para poder executar as tarefas.&lt;br /&gt;3. Vontade para aprender colaborativamente: interagir, ser participativo no ensino a distância conta muitos pontos, pois irá colaborar para o processo ensino-aprendizagem pessoal, dos colegas e dos professores.&lt;br /&gt;4. Comportamentos compatíveis com a etiqueta: mostrar-se interessado em conhecer seus colegas de turma respeitando-os e fazendo ser respeitado pelo mesmo.&lt;br /&gt;5. Organização pessoal: planejar e organizar tudo é fundamental para facilitar a sua revisão e a sua recuperação de materiais.&lt;br /&gt;6. Vontade para realizar as atividades no tempo correto: anotar todas as suas obrigações e realizá-las em tempo real.&lt;br /&gt;7. Curiosidade e abertura para inovações: aceitar novas idéias e inovar sempre.&lt;br /&gt;8. Flexibilidade e adaptação: requisitos necessário à mudança tecnológica, aprendizagens e descobertas.9. Objetividade em sua comunicação: comunicar-se de forma clara, breve e transparente é ponto - chave na comunicação pela Internet.&lt;br /&gt;10. Responsabilidade: ser responsável por seu próprio aprendizado. O ambiente virtual não controla a sua dedicação, mas reflete os resultados do seu esforço e da sua colaboração.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-7622991607389819648?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/7622991607389819648/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=7622991607389819648' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/7622991607389819648'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/7622991607389819648'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2009/08/como-funciona-o-aprendizado-online.html' title='Como Funciona o Aprendizado Online'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-5613806135140176660</id><published>2009-07-28T23:16:00.000-03:00</published><updated>2009-07-28T23:17:30.723-03:00</updated><title type='text'>1º Seminário de Difusão Científica</title><content type='html'>Saiba mais através do link:&lt;br /&gt;&lt;br /&gt;&lt;br /&gt; &lt;a href="http://www.funpar.ufpr.br:8088/funpar/index.php?option=com_content&amp;view=article&amp;id=203:evento_jornalistas&amp;catid=1:latest-news&amp;Itemid=50"&gt;http://www.funpar.ufpr.br:8088/funpar/index.php?option=com_content&amp;view=article&amp;id=203:evento_jornalistas&amp;catid=1:latest-news&amp;Itemid=50&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-5613806135140176660?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/5613806135140176660/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=5613806135140176660' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/5613806135140176660'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/5613806135140176660'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2009/07/1-seminario-de-difusao-cientifica.html' title='1º Seminário de Difusão Científica'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-8208548556131202074</id><published>2009-07-18T13:18:00.001-03:00</published><updated>2009-07-18T13:21:17.578-03:00</updated><title type='text'>Study Cites Hormones as Cancer Risk</title><content type='html'>&lt;a href="http://www.nytimes.com/2009/07/15/health/research/15cancer.html?_r=1&amp;ref=research"&gt;http://www.nytimes.com/2009/07/15/health/research/15cancer.html?_r=1&amp;ref=research&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Fundamentos Éticos e Bioéticos Das Resoluções  Sobre  a  Ética em  Pesquisa no  Brasil. &lt;br /&gt;      &lt;br /&gt;&lt;a href="http://www.cfh.ufsc.br/ethic@/et61art6.pdf"&gt;http://www.cfh.ufsc.br/ethic@/et61art6.pdf&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-8208548556131202074?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/8208548556131202074/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=8208548556131202074' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/8208548556131202074'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/8208548556131202074'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2009/07/study-cites-hormones-as-cancer-risk.html' title='Study Cites Hormones as Cancer Risk'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1548128325933368660.post-3189054941436183868</id><published>2009-07-05T14:35:00.000-03:00</published><updated>2009-07-05T14:36:55.858-03:00</updated><title type='text'>Multiple Sclerosis - Clinical Trials</title><content type='html'>Clinical Trials&lt;br /&gt;&lt;br /&gt; &lt;a href="http://clinicaltrials.gov/ct2/results?term=bg00012"&gt;http://clinicaltrials.gov/ct2/results?term=bg00012&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Links:&lt;br /&gt;&lt;br /&gt;   &lt;a href="http://www.msclinicalstudies.com/resources/index.htm"&gt;http://www.msclinicalstudies.com/resources/index.htm&lt;/a&gt;&lt;br /&gt;&lt;br /&gt; Vídeo:&lt;br /&gt;&lt;br /&gt;   &lt;a href="http://www.worldmsday.org/video?lang=es"&gt;http://www.worldmsday.org/video?lang=es&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1548128325933368660-3189054941436183868?l=esaude.eassertiva.com.br' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://esaude.eassertiva.com.br/feeds/3189054941436183868/comments/default' title='Postar comentários'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=1548128325933368660&amp;postID=3189054941436183868' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/3189054941436183868'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1548128325933368660/posts/default/3189054941436183868'/><link rel='alternate' type='text/html' href='http://esaude.eassertiva.com.br/2009/07/multiple-sclerosis-clinical-trials.html' title='Multiple Sclerosis - Clinical Trials'/><author><name>eHealth -  Telessaúde -Pesquisa Clínica</name><uri>http://www.blogger.com/profile/17230076563828176211</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='01615546091578927413'/></author><thr:total>0</thr:total></entry></feed>